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CHAPTER 1 
INTRODUCTION 
 
Parts of this chapter have been submitted for publication to the journal BioMed 
Research International. 
 
Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, is 
crucial for mitochondrial function and is involved in various cellular processes outside 
of the mitochondria. The importance of CL in cardiovascular health is underscored by 
the life-threatening genetic disorder Barth syndrome (BTHS), which manifests clinically 
as cardiomyopathy, skeletal myopathy, neutropenia, and growth retardation. In 
addition to BTHS, CL is linked to various cardiovascular diseases (CVDs), including 
cardiomyopathy, atherosclerosis, myocardial ischemia-reperfusion injury, heart failure 
and Tangier disease. The link between CL and CVDs may possibly be explained by 
the physiological roles of CL in pathways that have cardioprotective function, such as 
autophagy/mitophagy and the mitogen-activated protein kinase (MAPK) pathways. My 
dissertation work focuses on elucidating how CL influences mitophagy and MAPK 
pathways. This knowledge may contribute to our understanding of the function of this 
important lipid, and may ultimately identify novel therapeutic strategies to treat CVDs 
and improve heart performance. 
 
1. CL and CL synthesis 
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CL contains two phosphatidyl moieties joined by a central glycerol backbone, 
forming a dimeric structure (De Bruijn, 1966). Thus, unlike other phospholipids that 
contain two fatty acyl chains linked to glycerol, CL has four acyl chains. Considering 
the potential combinations of fatty acyl groups on CL, a large number of CL species 
may be possible. However, in most organisms and tissues, the fatty acyl composition 
of CL is unique and specific. For example, bacterial CL contains both saturated and 
monounsaturated fatty acyl chains that are composed of 14–19 carbons (Kito et al., 
1972). In eukaryotes, CL mainly contains monounsaturated and diunsaturated fatty 
acyl chains that consist of 16–18 carbons (Schlame et al., 1993). In mammals, CL acyl 
species vary in different tissues, but the most abundant species in the heart is 
tetralinoleoyl CL. In yeast, the predominant fatty acyl species of CL are oleic acid and 
palmitoleic acid (Schlame et al., 1993). While CL plays critical roles in mitochondrial 
biogenesis, fusion and fission, respiration and protein import (Joshi et al., 2009), it is 
also involved in various cellular processes outside of the mitochondria. These include, 
but are not limited to cell wall biogenesis (Zhong et al., 2005), vacuole homeostasis 
(Chen et al., 2008b), ageing (Zhou et al., 2009), the cell cycle (Chen et al., 2010), and 
apoptosis (Li et al., 2015).  
Unlike mitochondrial membrane lipids that are synthesized in the endoplasmic 
reticulum, de novo synthesis of CL occurs exclusively in the inner membrane of the 
mitochondria (Hostetler et al., 1972) in a series of well-characterized steps that are 
conserved from yeast to higher eukaryotes (Tian et al., 2012). The first step in the CL 
biosynthetic pathway is the conversion of phosphatidic acid (PA) to CDP-diacylglycerol 
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(CDP-DAG), which is catalyzed in the inner membrane by CDP-DAG synthase 
encoded by TAM41 (Deprez et al., 2002; Kutik et al., 2008; Tamura et al., 2013). The 
PGS1-encoded phosphatidylglycerolphosphate (PGP) synthase catalyzes transfer of 
the phosphatidyl group from CDP-DAG to a glycerol-3-phosphate molecule to generate 
PGP (Chang et al., 1998b). PGP is subsequently dephosphorylated to 
phosphotidylglycerol (PG) by PGP phosphatase, encoded by PTPMT1 in mammals 
(Xiao et al., 2011; Zhang et al., 2011) and GEP4 in yeast (Osman et al., 2010).  The 
final step in the biosynthetic pathway is carried out by CL synthase, encoded by hCLS1 
in human cells (Chen et al., 2006; Houtkooper et al., 2006; Lu et al., 2006) and by 
CRD1 in yeast (Chang et al., 1998a; Jiang et al., 1997; Tuller et al., 1998). In this step, 
a second phosphatidyl group is added to PG from another CDP-DAG molecule, 
generating CL (Hostetler et al., 1972; Houtkooper et al., 2006; Malhotra et al., 2009).  
The acyl composition of CL varies in different tissues, and the CL remodeling 
process is responsible for the CL acyl group exchange following CL de novo synthesis. 
CL remodeling may occur through two mechanisms (Ye et al., 2014b). In the two-step 
mechanism, CL is first deacylated to monolyso-CL (MLCL) by phospholipases (Lands, 
1960). In yeast, the only CL-specific phospholipase is encoded by CLD1 (Beranek et 
al., 2009), while in mammals, several phospholipases are reported to have CL-
hydrolyzing activities, including iPLA2β, iPLA2γ, cPLA2, and sPLA2 (Buckland et al., 
1998; Dennis et al., 2011; Hsu et al., 2013). MLCL is reacylated to remodeled CL by 
the transacylase tafazzin, encoded by the tafazzin gene (TAZ/G4.5) located on Xq28 
in human cells (Bione et al., 1996) and by TAZ1 in yeast (Gu et al., 2004; Vaz et al., 
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2003). Acyltransferases encoded by ALCAT1 (Cao et al., 2004) and MLCLAT1 (Taylor 
and Hatch, 2009) have also been described in mammalian cells. In the one-step 
mechanism, CL remodeling occurs by direct transacylation (Xu et al., 2003; Yamashita 
et al., 1997). Mutations in tafazzin perturb CL remodeling and cause the life-
threatening genetic disorder Barth syndrome (BTHS) (Barth PG et al., 1983), which is 
discussed below.  
The CL synthesis and remodeling pathway in my research model, 
Saccharomyces cerevisiae, is shown in Fig. 1.1. 
 
2. Relationship between CL and CVD  
2.1 CL and cardiomyopathy 
2.1.1 Barth syndrome 
The most direct link between CVD and CL is seen in BTHS, an X-linked genetic 
disorder of CL remodeling caused by tafazzin mutations. BTHS manifests clinically as 
cardiomyopathy, skeletal myopathy, neutropenia, and growth retardation (Barth et al., 
1999). More than 160 mutations in the tafazzin gene have been identified in BTHS 
patients (Chen et al., 2002; D'Adamo et al., 1997; Hijikata et al., 2015). These 
mutations result in loss of function of tafazzin, leading to decreased cellular CL, 
increased MLCL, and altered CL fatty acyl composition (Schlame et al., 2003; Schlame 
et al., 2002; Valianpour et al., 2002). Total CL is decreased to about 80% in BTHS 
platelets and skeletal muscle and 20% in cardiac tissue (Schlame et al., 2002). CL 
species vary in different tissues. Tetralinoleoyl-CL (L4-CL) is the most abundant  
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Fig. 1.1 Cardiolipin synthesis and remodeling pathway in Saccharomyces 
cerevisiae. Cited from Ye et al. 2014b. Cited from Ye et al. 2014b. The first 
reaction of CL de novo synthesis is the conversion of phosphatidic acid (PA) to 
CDP-diacylglycerol (CDP-DAG) by the mitochondrial CDP-DAG synthase 
Tam41. The committed step of CL synthesis is catalyzed by Pgs1, which 
converts CDP-DAG to phosphatidylglycerolphosphate (PGP). PGP is 
subsequently dephosphorylated to phosphatidylglycerol (PG) by the GEP4-
encoded PGP phosphatase. CL synthase, encoded by CRD1, condenses PG 
and CDP-DAG to form CL. CL synthesized de novo has primarily saturated acyl 
chains (CLSAT). CLSAT is deacylated by the CL-specific phospholipase Cld1 to 
monolysocardiolipin (MLCL), which is reacylated by tafazzin (the TAZ1 gene 
product) to CL containing more unsaturated acyl chains (CLUNSAT). All the CL 
biosynthetic enzymes are localized in the mitochondrial inner membrane (IM), 
whereas tafazzin is localized in the outer face of the (IM) and the inner face of 
the outer membrane (OM). IMS: intermembrane space. 
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CL species in heart, skeletal muscle and most other tissues, whereas acyl species 
such as arachidonic and docosahexaenoic acids are found in brain (Cheng et al., 2008; 
Houtkooper and Vaz, 2008; Schlame and Ren, 2006). L4-CL is absent in BTHS, 
while increases in other CL species are present (Schlame et al., 2003; Schlame et al., 
2002; Valianpour et al., 2002).  
Understanding the cellular function and molecular mechanisms of CL remodeling 
may provide better treatment options for BTHS patients (Ye et al., 2014b). Tafazzin 
deficiency results in decreased CL, increased MLCL, and altered CL species, any of 
which may cause the pathology in BTHS. Recent findings in yeast indicate that deletion 
of Cld1p-mediated deacylation rescues growth and lifespan defects in tafazzin 
deficient cells (Baile et al., 2013; Ye et al., 2014a). Because the cld1 mutation restored 
CL levels without generating remodeled CL, these findings suggest that decreased 
total CL and/or increased MLCL, but not decreased remodeled CL, causes the defects 
associated with tafazzin deficiency. Inhibiting CL deacylation may, thus, be a potential 
strategy to treat BTHS patients.  
 
2.1.2 Dilated cardiomyopathy with ataxia (DCMA) syndrome 
DCMA syndrome is an autosomal recessive genetic disorder that is 
characterized by early onset dilated cardiomyopathy with conduction defects, non-
progressive cerebellar ataxia, testicular dysgenesis, growth failure, and 3-
methylglutaconic aciduria (Davey et al., 2006). These clinical manifestations are similar 
to phenotypes found in BTHS. Patients with DCMA have a common mutation, a GC 
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base substitution within a splice site of the DNAJC19 gene (Davey et al., 2006). 
DNAJC19 protein localizes to the mitochondria and shares sequence and location 
similarity with yeast Tim14, an essential subunit of the TIM23 complex (D'Silva et al., 
2003; Mokranjac et al., 2003). TIM23 is required for the import of protein precursors 
from the cytoplasm into the mitochondrial matrix and inner membrane (Rehling et al., 
2003). This suggests that the DCMA phenotype may result from defective 
mitochondrial protein import. Interestingly, loss of CL also leads to defective 
mitochondrial protein import (Eilers et al., 1989; Endo et al., 1989; Endo and Schatz, 
1988; Gebert et al., 2009; Jiang et al., 2000). Therefore, it is interesting to speculate 
that defective mitochondrial protein import may be common to DCMA and BTHS. A 
recent study suggests that CL may play a role in the pathogenesis of DCMA (Richter-
Dennerlein et al., 2014). DNAJC19 protein is reported to form the PHB/DNAJC19 
complex with prohibitin, a ring-like scaffold protein located in the mitochondrial inner 
membrane. The PHB/DNAJC19 complex modulates CL remodeling by regulating 
tafazzin activity. Depletion of DNAJC19 does not affect CL or MLCL levels but alters 
the acyl chain composition of CL (Richter-Dennerlein et al., 2014). However, if the 
cause of DCMA is due to defective protein import, altered CL fatty acyl species, or a 
combination of the two remains unknown. 
 
2.1.3 Diabetic cardiomyopathy 
Diabetes is a metabolic disease characterized by increased levels of glucose in 
the blood over a prolonged period. It is due to either poor insulin production (type I) or 
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insulin resistance with β-cell dysfunction (type II) (He and Han, 2014). 
Diabetic complications are characterized by  a group of diseases derived from 
microvascular and macrovascular damage, including diabetic cardiomyopathy, 
myonecrosis, stroke, peripheral vascular disease, nephropathy, retinopathy 
and encephalopathy (Nathan, 1993). Diabetes doubles the risk of CVD, of which 
diabetic cardiomyopathy is the leading cause of mortality. Diabetic cardiomyopathy is 
characterized by altered lipid composition and mitochondrial dysfunction in the diabetic 
myocardium (Han et al., 2000). In the early stages of pathological development in the 
type II diabetic mouse model, a sharp decrease in total cardiac CL is observed (Han 
et al., 2005). In addition to a decrease in the whole cell CL content, there is also a shift 
from the predominant fatty acyl species, L4-CL (18:2) to longer and polyunsaturated 
fatty acids, due to aberrant CL remodeling (Han et al., 2007). Strikingly, these 
alterations are similar to changes observed in the type I model of diabetes. In type II 
diabetic mice, treatment with the antidiabetic drug rosiglitazone restored total CL, L4-
CL, and polyunsaturated CL levels (Pan et al., 2006). Impairment of CL synthesis plays 
a causal role in mitochondrial dysfunction (Koshkin and Greenberg, 2002; 
Mileykovskaya and Dowhan, 2014a; Pfeiffer et al., 2003), and mitochondrial 
dysfunction is associated with the pathogenesis of diabetic CVD, especially the 
sequential events following silent myocardial ischemia in diabetics (Sack, 2009). Thus, 
the sharp decrease in total cardiac CL and the altered CL fatty acyl species in the early 
stages of diabetic pathogenesis may play a key role in the progression of this disease. 
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2.2 CL is associated with other CVDs 
In addition to its role in cardiomyopathy, CL has been linked to other CVDs, 
including atherosclerosis, Tangier disease, myocardial ischemia-reperfusion and heart 
failure. 
Atherosclerosis is a form of arteriosclerosis in which an artery wall thickens due 
to chronic invasion and further accumulation of white blood cells (WBC), remnants of 
dead cells, cholesterol, and triglycerides (Ross, 1993). Oxidized CL (oxCL) was found 
to accumulate both in rabbit and human atherosclerotic lesions (Tuominen et al., 2006), 
and in the aortic root of mice fed a high fat diet (Zhong et al., 2014). Increased anti-
oxCL IgG (Lopez et al., 2003; Marai et al., 2008; Türkoğlu et al., 2008) and IgM (Su et 
al., 2013; Türkoğlu et al., 2008) antibodies are associated with atherosclerosis 
development. oxCL is recognized as a natural antigen that stimulates pro-inflammatory 
effects in the artery and promotes formation of atherosclerotic plaques (Bochkov et al., 
2010; Marai et al., 2008). However, some studies purport that autoantibodies to oxCL 
may serve a protective role against the onset and development of atherosclerosis 
(Frostegård et al., 2014; Su et al., 2006). The seemingly contradictory findings 
regarding the role of anti-oxCL antibodies in atherosclerosis may reflect the influence 
of other factors, including age, gender and existing diseases. The anti-coagulation 
protein annexin A5 has been reported to bind to and inhibit the pro-inflammatory effects 
of oxCL (Wan et al., 2014), providing the basis of a promising therapeutic strategy for 
oxCL-positive atherosclerosis.    
Tangier disease (TD) is another genetic disorder that may be linked to CL. TD is 
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a disorder of cholesterol efflux and lipid metabolism characterized by a nearly complete 
absence of plasma high-density lipoproteins (HDLs), atherosclerosis, peripheral 
neuropathy and an increased risk for developing CVD (Fredrickson, 1964; Oram, 
2000). The genetic cause of TD is mutations of the ABCA1 gene, which is located on 
chromosome 9 (Rust et al., 1999). ABCA1 encodes a highly conserved ATP binding 
cassette transporter that belongs to a subfamily of ABC transporters. The ABCA 
subfamily is involved in lipoprotein metabolism and lipid transport across the plasma 
membrane (Knight, 2004). Researchers propose that a physical interaction between 
apoA-I and ABCA1 results in the formation of a phospholipid-apoA-I complex that 
promotes cholesterol efflux (Wang et al., 2001). Three phospholipids, including CL and 
lysoCL 1 and 2 (LC1 and LC2), which together contribute only a small fraction of the 
total cellular phospholipid content, were found to be enriched up to five-fold in TD 
fibroblasts compared to wild type (WT) cells (Fobker et al., 2001). This finding suggests 
that phospholipid and cholesterol efflux may be co-regulated and, therefore, dually 
impaired in TD cells. Additionally, it is possible that increased CL may play an as yet 
uncharacterized regulatory role in cholesterol trafficking and efflux.  
In addition to the above disorders, the CL profile is altered in both myocardial 
ischemia-reperfusion injury and heart failure. Myocardial ischemia occurs when the 
myocardium does not receive sufficient blood flow, resulting in cell death and 
further irreversible injury (Carden and Granger, 2000). Restoration of circulation in 
ischemic myocardium exacerbates the injury (Carden and Granger, 2000). In the early 
stages of myocardial ischemia, there is an increase in reactive oxygen species (ROS). 
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During and post ischemia-reperfusion, ROS is thought to trigger lipid peroxidation as 
well as damage to cellular macromolecules and the electron transport chain, which 
together lead to apoptosis, necrosis and tissue damage (Ferrari et al., 1991; Kalogeris 
et al., 2014; Kloner et al., 1989). Unsaturated CL acyl species in the mitochondrial inner 
membrane that are close to the site of ROS generation are vulnerable to oxidative 
damage. Consistent with this, total CL was decreased and peroxidized CL was 
increased in the rat heart during ischemia-reperfusion (Paradies et al., 1999). A study 
of ischemia-reperfusion in rabbit heart reported that reduction of total CL was due in 
large part to a significant decrease in CL in the subsarcolemmal mitochondria, whereas 
CL in the interfibrillar mitochondria was unchanged (Lesnefsky et al., 2001). The levels 
of all other phospholipids remained unaffected in the same study. Decreased CL was 
shown to have an impact on electron transport chain complexes I (Paradies et al., 
2004), III (Petrosillo et al., 2003), and IV (Paradies et al., 1999). The enzyme activies 
of these complexes in mitochondria from the ischemic rat heart was restored by the 
addition of exogenous CL, but not by other phospholipids or peroxidized CL (Paradies 
et al., 1999). In summary, a feedback loop appears to be formed, in which CL is 
damaged by ischemia-reperfusion-induced ROS, and damaged CL leads to 
impairment of electron transport chain complexes, resulting in the generation of more 
ROS. In addition, the fact that membranes containing peroxidized CL are more 
permeable to apoptosis factors (Korytowski et al., 2011) may suggest a route through 
which ROS triggers apoptosis and tissue damage. 
Heart failure (HF) occurs when the heart is not able to contract efficiently enough 
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to pump blood to meet the body’s needs. The major clinical symptoms of HF include 
edema, shortness of breath and lack of energy. HF is usually the end stage of CVD, 
including cardiomyopathy, heart attack, cardiac valvular disease, atrial fibrillation, and 
high blood pressure (McMurray and Pfeffer).  In both the spontaneously hypertensive 
HF rat (SHHF) and human HF patients, decreased tafazzin mRNA levels were 
observed, concomitant with compensatory increases in the activity of 
phosphatidylglycerolphosphate synthase and MLCL acyltransferase (Saini-Chohan et 
al., 2009). However, studies of the CL profile in HF are controversial. While most 
studies report a significant reduction of total CL and L4-CL in human HF (Chatfield et 
al.; Le et al., 2014; Sparagna et al., 2007) and in the rat HF model (Reibel et al., 1986; 
Sparagna et al., 2007), one study reported an unchanged CL profile in a rat model with 
intracoronary microembolization-induced HF (Rosca et al., 2011). It is likely that 
different HF pathogenesis mechanisms lead to varying degrees of CL profile change 
and mitochondrial damage. 
 
3 CL plays a role in cellular events and pathways that are important for 
maintaining cardiovascular health 
3.1 Autophagy/mitophagy 
Autophagy refers to the cellular process in which cytoplasmic contents are 
delivered to the lysosome or vacuole for degradation. Autophagy is further classified 
into selective and nonselective autophagy (Nair and Klionsky, 2005). Various types of 
selective autophagy have been identified, including mitophagy, pexophagy, lipophagy, 
nucleophagy, lysophagy, reticulophagy/ER-phagy and ribophagy (Okamoto, 2014). 
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Mitophagy is the selective degradation of mitochondria by autophagy (Wang and 
Klionsky, 2011). Mitophagy and autophagy are generally not distinguished in studies 
of CVD and will be discussed together here. 
In the heart, autophagy is an important housekeeping process and is essential 
for maintaining cardiac health (Moyzis et al., 2015). Autophagic activity declines with 
age, and decreased or impaired autophagy leads to accumulation of proteins and 
damaged mitochondria, contributing to cardiac aging (Linton et al.). In addition, 
deletion of ATG5, the gene encoding a protein that regulates phagophore expansion, 
is known to result in cardiomyopathy in mice (Nakai et al., 2007). 
As discussed above, decreased CL causes impairment of the electron transport 
chain complexes I (Paradies et al., 2004), III (Petrosillo et al., 2003) and IV (Paradies 
et al., 1999), resulting in mitochondrial dysfunction. In response to mitochondrial 
damage, mitophagy increases as an adaptive and protective strategy to eliminate 
damaged mitochondria (Frank et al., 2012; Narendra et al., 2008). Therefore, I 
undertook the study in this thesis to investigate if the loss of CL leads to altered 
mitophagy. 
 
3.2 CL and MAPK pathways 
3.2.1 PKC pathway 
Protein kinase C (PKC) is a family of protein kinases that regulate the function of 
other proteins through specific phosphorylation of hydroxyl groups on threonine 
and serine residues. Human cells have fifteen PKC isozymes (Mellor and Parker, 
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1998). Over-stimulation of PKCα, PKCβ, PKCδ or PKCε results in hypertrophy of 
cardiomyocytes through activation of the extracellular signal-related kinase (ERK) 
pathway (Steven P. Marso and Stern, 2003). However, during ischemia preconditioning, 
PKCα, PKCδ, PKCε and PKCη have been shown to translocate to the active 
membrane pool and perform cardioprotective functions (Steven P. Marso and Stern, 
2003). Activation of PKCδ results in intracellular pH changes and viability protection; 
activation of PKCη protects against myocardial stunning; activation of both PKCδ and 
PKCη provides global myocardial protection against necrosis, acidosis, and 
myocardial stunning (Meldrum et al.). Blocking the phosphatidylinositol-specific 
phospholipase C (PI-PLC)-induced translocation of PKCα, PKCε, and PKCη during 
ischemia impairs myocardial recovery (Munakata M et al., 2002). Therefore, PKC 
isozymes have dual functions in the pathogenesis and progression of CVD. However, 
unlike other PKC isozymes that affect different CVDs, PKCη is mainly reported to play 
a cardioprotective role during ischemia.  
Yeast has only one PKC (Pkc1p). Human PKCη is the only human PKC isozyme 
that can complement the defects caused by deletion of PKC1 in yeast through 
activation of the same protein kinase cascade (Nomoto S et al., 1997). This suggests 
that PKCη shares both functional and structural homology with Pkc1p. A previous study 
in yeast showed that loss of PG, the precursor of CL, leads to defects in the activation 
of the PKC pathway (Zhong et al., 2007). Extrapolating from the finding in yeast that 
the CL precursor is required for PKC pathway activation, the cardioprotective role of 
PKCη activation during ischemia preconditioning may be dependent on CL. In yeast, 
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PKC activation is also required for mitophagy (Mao et al., 2011), another 
cardioprotective process. Thus, to investigate how CL plays a role in maintaining 
cardiovascular health, it is necessary to determine if CL is required for PKC pathway 
activation.  
 
3.2.2 HOG pathway 
The high osmolarity glycerol (HOG) pathway is a highly conserved MAPK 
pathway that mediates the cellular response to hyperosmotic shock. In yeast, the HOG 
pathway consists of two stress-sensing branches, SLN1 and SHO1 branches (Saito 
and Tatebayashi, 2004). Both branches are cascades that lead to phosphorylation of 
Hog1p, the yeast homolog of the mammalian MAPK p38, which functions in 
the inflammatory and stress responses (Raingeaud et al., 1995). Phosphorylation 
activates Hog1p and promotes translocation into the nucleus. The phosphorylated 
protein (pHog1p) induces transcription of GPD1, and GPP2, which encode glycerol-3-
phosphate dehydrogenase and glycerol-3-phosphate phosphatase, respectively (Rep 
et al., 2000). These enzymes are involved in the production of glycerol, the cytosolic 
accumulation of which counteracts osmotic stress. Activated Hog1p also regulates 
intracellular ion homeostasis by phosphorylating the C-termini of Nha1p, the Na+/H+ 
antiporter on the plasma membrane, and Tok1p, the potassium channel on the plasma 
membrane (Proft and Struhl, 2004). In addition to regulating glycerol biogenesis and 
ion homeostasis, pHog1p regulates the transcription of about 600 genes, resulting in 
cellular adaptation to various stresses (O'Rourke and Herskowitz, 2004).  
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A previous study showed that CL mutants exhibit vacuole defects that are 
characterized by enlarged vacuoles and loss of vacuole acidification (Chen et al., 
2008b). The vacuole defects were rescued by deletion of NHX1, which encodes the 
Na+/H+ and K+/H+ exchanger, suggesting that ion homeostasis is perturbed in CL 
mutants. The vacuole defects were also rescued by supplementation with 1 M sorbitol, 
a HOG pathway stimulant, suggesting that osmoregulation may be perturbed in CL 
mutants. Because the HOG pathway functions in both osmoregulation and intracellular 
ion homeostasis, it is necessary to determine if the HOG pathway is perturbed in CL 
mutants. 
 
4  Saccharomyces cerevisiae as my research model 
As discussed above, CL biosynthesis is highly conserved from yeast to humans. 
The yeast taz1Δ mutant exhibits respiratory and metabolic deficiencies similar to those 
in human BTHS cells (Chen et al., 2008a; Gu et al., 2004; Ma et al., 2004). In addition, 
the availability of null mutants for each step of CL synthesis facilitates studies to 
elucidate CL function, which are not easily carried out in higher eukaryotes. For 
example, the finding that growth and respiratory defects of the yeast taz1 mutant are 
rescued by deletion of CLD1, which restores CL/MLCL levels without generating 
remodeled CL, suggests that CL/MLCL levels are more important for mitochondrial 
function than CL acyl composition (Baile et al., 2014; Ye et al., 2014a). This study could 
not be carried out in mammalian cells, as CL phospholipases have not been 
characterized in mammals.  
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Most of the studies described in this thesis utilize the crd1Δ null mutant, in which 
the gene for CL synthase is deleted. The crd1Δ mutant has no CL and accumulates 
the CL precursor, PG. I also utilized the yeast genome deletion collection, which 
facilitated me to carry out genetic interaction studies. The genetic and molecular tools 
of the yeast model enabled me to carry out my analysis of the role of CL in mitophagy 
and the MAPK pathways. 
 
5  Project outline 
The goal of my doctoral research was to investigate the role of CL in cellular 
events and pathways that are required for maintaining cardiovascular health. I 
specifically focused on the role of CL in mitophagy, and the mechanism underlying this 
connection. 
The study described in Chapter 2 shows that the loss of CL leads to defective 
mitophagy. Synthetic lethality with autophagy/mitophagy mutants suggested that 
mitophagy may be deficient in crd1Δ. Microscopic examination of mitophagy revealed 
decreased translocation of GFP-tagged mitochondrial protein into the vacuole of crd1Δ 
cells. This was confirmed by immunoblotting detection of free GFP, which was 
generated by cleavage of GFP-tagged mitochondrial protein after it was delivered into 
the vacuole by mitophagy. These findings indicated that mitophagy is decreased in CL 
deficient cells.  
Chapter 3 describes a possible mechanism underlying defective mitophagy in 
crd1Δ. It is known that the PKC pathway is required for early stages of mitophagy and 
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the HOG pathway is required for later stages (Mao et al., 2011). My studies showed 
that crd1Δ growth defects are exacerbated by downregulation of the HOG pathway 
and rescued by upregulating the PKC pathway, suggesting that these MAPK pathways 
may be defective in CL mutants. Consistent with this, Western blot experiments 
showed decreased phosphorylation of Slt2p and Hog1p in crd1Δ, indicating defective 
activation of the PKC and HOG pathways. Interestingly, upregulation of PKC rescued 
defective mitophagy in crd1Δ. These results suggest that the mechanism underlying 
defective mitophagy in crd1Δ cells is defective MAPK function. 
Although the findings of my dissertation research shed light on the role of CL in 
pathways known to be important for maintaining cardiovascular health, the story is far 
from over. Chapter 4 describes exciting experiments that can be done to elucidate the 
mechanism underlying the role of CL in mitophagy and the MAPK pathways. In addition, 
follow up experiments are proposed to continue preliminary studies of the role of CL in 
vacuole homeostasis.  
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   CHAPTER 2 
LOSS OF CARDIOLIPIN LEADS TO DEFECTIVE MITOPHAGY 
Introduction 
Cardiolipin (CL) is the signature lipid of mitochondrial membranes. It plays an 
important role in mitochondrial function through interacting with various mitochondrial 
membrane proteins, including electron transport chain (ETC) complex proteins that 
are components of complex I (Fry and Green, 1981; Mileykovskaya and Dowhan, 
2014b), complex III (Fry and Green, 1981; Pfeiffer et al., 2003; Zhang et al., 2002; 
Zhang et al., 2005), complex IV (Pfeiffer et al., 2003; Zhang et al., 2002; Zhang et al., 
2005), complex V (Gohil et al., 2004), cytochrome c (Ranieri et al., 2015) and 
transporter proteins such as the ADP-ATP carrier (Beyer K and M., 1985), pyruvate 
carrier (Paradies and Ruggiero, 1988) and phosphate carrier (Kadenbach et al., 1982). 
Loss of CL leads to impaired mitochondrial function, including defective respiration 
(Schlame and Ren, 2006), decreased mitochondrial membrane potential (Jiang et al., 
2000) and impaired mitochondrial protein import (Gebert et al., 2009; Jiang et al., 
2000). Additional cellular functions of CL outside of mitochondria are continuously 
being explored. 
In studies described in this chapter, I investigated the role of CL in mitophagy. 
Mitophagy is the selective degradation of mitochondria through autophagy (Wang and 
Klionsky, 2011). Autophagy is the cellular process in which cytoplasmic contents are 
delivered into the lysosome or vacuole for degradation. According to the different ways 
by which cargos are delivered to the lysosome/vacuole for degradation, autophagy is 
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classified as macroautophagy, microautophagy, and chaperone-mediated autophagy 
(Shintani and Klionsky, 2004). Autophagy is further classified as selective or 
nonselective, depending on whether specific cargo is selected (Nair and Klionsky, 
2005). Various types of selective autophagy have been identified (Okamoto, 2014), 
among which mitophagy is the selective degradation of mitochondria (Wang and 
Klionsky, 2011). In the heart, autophagy is essential for maintaining cardiac health 
(Moyzis et al., 2015). Impairment of the process by deletion of ATG5 has been 
demonstrated to cause cardiomyopathy in mice (Nakai et al., 2007), linking abnormal 
autophagy to cardiomyopathy. 
Cardiomyocytes have a remarkably high mitochondrial density that comprises 
about 30% of the total intracellular volume (Maack and O’Rourke, 2007). This allows 
cardiomyocytes to produce ATP quickly to satisfy the high demand for energy. Even 
subtle alterations in mitochondrial function or membrane potential can cause a 
significant change in cardiomyocyte energy production and further harm 
cardiovascular health. In response to mitochondrial damage, mitophagy increases as 
an adaptive and protective strategy (Frank et al., 2012; Narendra et al., 2008). 
Therefore, I carried out studies to determine if loss of CL, which perturbs numerous 
mitochondrial functions, leads to altered mitophagy. 
Genetic interaction analysis is a very powerful approach to study gene function. 
Rescue of a mutant phenotype by deletion of another gene identifies suppression of 
the mutant phenotype. Exacerbation of a mutant phenotype to lethality by deletion of 
another gene is defined as synthetic lethality, which suggests that the two genes may 
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work in redundant pathways. I predicted that genetic interaction analysis between 
autophagy/mitophagy genes and CRD1 would shed light on the role of CL in mitophagy.  
Although mitophagy occurs via both macro- and micro-autophagy (Kanki et al., 
2009c; Kiššová et al., 2007; Nowikovsky et al., 2007; Okamoto et al., 2009), 
degradation of mitochondria via macro-autophagy is the dominant process when 
mitophagy is triggered by nitrogen starvation or glucose deprivation (Kiššová et al., 
2007). During macro-mitophagy, mitochondria are recognized as the cargo that is 
brought to the phagophore assembly site (PAS), where the double-membrane of the 
phagophore expands and closes to form a mature mitophagosome that contains 
mitochondria. Macro-mitophagy adapts the general autophagy core machinery, which 
involves various autophagy-related (ATG) proteins, including the Atg1p/Atg13p 
complex, Atg9p, Atg18p-Atg2p complex, Atg8p conjugation system (Atg3p, Atg4p, 
Atg7p, and Atg8p), and the Atg12 ubiquitin-like conjugation system (Atg5p, Atg7p, 
Atg10p, Atg12p, and Atg16p) (Köfinger et al., 2015; Reggiori et al., 2005; Reggiori et 
al., 2004; Sakoh-Nakatogawa et al., 2015; Suzuki et al., 2001; Suzuki et al., 2007; Xie 
and Klionsky, 2007). Atg8p is the yeast homolog of mammalian LC3, and it is 
conjugated to phosphatidylethanolamine (PE) (Kirisako et al., 1999). Atg8p-PE coats 
the mitophagosome membrane during membrane elongation. Phosphatidylinositol 3-
phosphate (PI3P) is another important lipid that constitutes the mitophagosome 
membrane (Gillooly et al., 2000). Atg18p binds to PI3P and regulates the retrieval of 
Atg9p from PAS, and normal transport of Atg9p between PAS and the peripheral site 
is essential in PI3P synthesis on the mitophagosome membrane (Reggiori et al., 
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2005). Thus, Atg8p and Atg18p are essential proteins in the general autophagy core 
machinery.  
The mitochondrial outer membrane protein Atg32p plays a key role in selecting 
mitochondria as the specific cargo. When mitophagy is triggered, Atg32p is 
phosphorylated (Aoki et al., 2011). Then it interacts with Atg11p, which directs 
mitochondria to the PAS, where an Atg32–Atg11–Atg8 initiator complex is formed 
(Aoki et al., 2011; Farré et al., 2013). When an intact mitophagosome is formed and 
delivered to the vacuole, the mitophagosome outer membrane fuses with the vacuole 
membrane and releases the mitochondria wrapped by the mitophagosome inner 
membrane into the vacuole lumen for degradation. 
In this chapter, I investigated if loss of CL in the crd1Δ mutant leads to altered 
mitophagy. Deletion of autophagy/mitophagy genes exacerbated the crd1Δ growth 
defect. Mito-GFP marker tracking experiments and Western detection of free GFP, the 
mitophagy product, both showed inhibited mitophagy in crd1Δ compared to WT. These 
findings suggest that CL plays a novel role in mitophagy.  
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Methods and materials 
Yeast strains and growth media 
The Saccharomyces cerevisiae strains used in this work are listed in Table 2.1. 
Yeast extract peptone dextrose (YPD) medium contained yeast extract (1%), peptone 
(2%), and glucose (2%). Synthetic complete (SC) medium contained lab-made 
vitamin-free yeast nitrogen base without amino acids (Difco protocol, 0.17% ), 
ammonium sulfate (0.5%), glucose (2%), vitamins, and the following amino acids: 
adenine (20.25 mg/liter), arginine (20 mg/liter), histidine (20 mg/liter), leucine (60 
mg/liter), lysine (200 mg/liter), methionine (20 mg/liter), threonine (300 mg/liter), 
tryptophan(20 mg/liter), and uracil (20 mg/liter). Synthetic drop-out medium contained 
all ingredients mentioned above except the amino acid used as the selective marker. 
Synthetic lactate (SL) medium contained lab-made vitamin free yeast nitrogen base 
without amino acids (Difco protocol, 0.17%), ammonium sulfate (0.5%), and lactate 
(2%). Solid medium contained agar (2%).  
 
Construction of deletion mutants and strains that express GFP-tagged 
mitochondrial proteins 
Deletion mutants were constructed as follows. The entire open reading frame of 
the target gene was replaced by a KanMX4 cassette via homologous recombination 
in the wild type (WT) strain. The KanMX4 cassette was amplified by polymerase chain 
reaction (PCR), using the pUG6 plasmid, which contains the KanMX4 cassette, as the 
24 
 
template. The amplification primers consisted of 50 nucleotides that were identical to 
either the upstream or the downstream flanking region of the target gene at the 5’ end 
and 21 nucleotides that annealed to the KanMX4 gene at the 3’ end. For construction 
of the single mutants with the target mitophagy gene deleted, the PCR product was 
transformed into the WT strain by electroporation. For construction of the double 
mutants with both CRD1 and the target mitophagy gene deleted, the PCR product 
was transformed into the crd1Δ strain by electroporation. Transformants were 
selected on YPD plates with 200 μg/ml G418. Deletion of the target gene was 
confirmed by PCR using primers that amplify the original target gene.  
To monitor mitophagy in both WT and crd1Δ strains, the mitochondrial matrix 
protein Idh1p in both strains was tagged by GFP as previously described (Kanki et al., 
2009a). The pFA6a-GFP (S65T)-HIS3MX6 plasmid (kindly provided by Dr. Daniel 
Klionsky, University of Michigan) was used as the PCR template to amplify a DNA 
fragment that encodes GFP with HIS3 as the selective marker. The primers consisted 
of 50 nucleotides that were identical to either the upstream or the downstream flanking 
region of the IDH1 ending code (TAA) at the 5’ end and 20 nucleotides that annealed 
to the GFP sequence on the plasmid at the 3’ end. The sequences of these primers 
are 5’-CTTCTACTACTGACTTCACGAATGAAATCATCAACAAATTATCTAC 
CATGCGGATCCCCGGGTTAATTAA-3’ and 5’-AATTTGAACACACTTAAGTTGCAG 
AACAAAAAAAAGGGGAATTGTTTTCAGAATTCGAGCTCGTTTAAAC-3’. The PCR 
product was then transformed into both WT and crd1Δ cells in the BY4742 and FGY 
genetic backgrounds by electroporation, and inserted into the end of the IDH1 locus 
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via homologous recombination. The transformants that express IDH1-GFP were 
selected on SC his- medium. Correct GFP insertion was confirmed by PCR analysis, 
using confirmation primers 5’-ATGCTGTCTTCGAACCAGGTT-3’ and 5’-
AGTTCATCCATGCCATGTGT-3’. 
Another approach to construct strains containing GFP-tagged mitochondria was 
to transform the pCu416-IDP1-GFP plasmid that expresses IDP1-GFP (kindly 
provided by Dr. Hagai Abeliovich, Hebrew University) into WT and crd1Δ, by 
electroporation. Transformants carrying the plasmid encoding IDP1-GFP were 
selected on SC ura- medium. 
 
Single colony formation analysis 
Cells were pre-cultured in YPD at 30˚C to the mid-log phase. The absorbance at 
550 nm (A550) of the liquid culture was determined using a spectrophotometer 
(Beckman). Cell aliquots were centrifuged and pellets were resuspended in YPD to 
adjust the A550 value to 10 units per ml. 10 μl of the above sample were added to 990 
μl of water. 10 μl of the 100X diluted sample were placed on a hemocytometer for cell 
counting using light microscopy at a magnification of 1000 X. Based on cell number, 
cell aliquots with A550 of 10 were adjusted again and serial diluted to 2000 cells/ml, 
from which 100 μl suspension that contained about 200 cells were plated on a YPD 
plate and incubated at 30˚C, 36˚C or 37˚C for 3 days. The ability of single cells to form 
colonies was evaluated at 30˚C, 36˚C or 37˚C. 
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Table 2.1 Yeast strains and plasmids used in Chapter 2 
Strain/plasmid Characteristics or genotype               Source or reference 
 
FGY3 (WT) 
FGY2 (crd1Δ) 
FGY3 atg8Δ 
FGY2 atg8Δ     
FGY3 atg18Δ 
FGY2 atg18Δ 
FGY3 atg32Δ 
FGY2 atg32Δ 
FGY3 atg21Δ 
FGY3 atg18Δatg21Δ 
FGY2 atg18Δatg21Δ 
FGY3‐IDH1‐GFP 
FGY2‐IDH1‐GFP 
BY4742  
VGY1 (BY4742 crd1Δ) 
BY4742‐IDH1‐GFP 
BY4742 crd1Δ-IDH1‐GFP 
 
pFA6a‐GFP(S65T)‐His3MX6 
pCu416‐IDP1‐GFP  
 
MAT α, ura3‐52, lys2‐801, ade2‐101, trp1Δ1, his3Δ200, leu2Δ1 
MAT α, ura3‐52, lys2‐801, ade2‐101, trp1Δ1, his3Δ200, leu2Δ1, crd1Δ::URA3 
Derivative of FGY3, atg8Δ::KanMX4 
Derivative of FGY2, atg8Δ::KanMX4 
Derivative of FGY3, atg18Δ::KanMX4 
Derivative of FGY2, atg18Δ::KanMX4 
Derivative of FGY3, atg32Δ::KanMX4 
Derivative of FGY2, atg32Δ::KanMX4 
Derivative of FGY3, atg21Δ::TRP1 
Derivative of FGY3, atg18Δ::KanMX4, atg21Δ::TRP1 
Derivative of FGY2, atg18Δ::KanMX4, atg21Δ::TRP1 
Derivative of FGY3, in which GFP is inserted into the IDH1 gene locus 
Derivative of FGY2, in which GFP is inserted into the IDH1 gene locus 
MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0 
MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0, crd1Δ::URA3 
Derivative of BY4742, in which GFP is Inserted into the IDH1 gene locus 
Derivative of BY4742  crd1Δ::KanMX4,  in which GFP  is  Inserted  into  the  IDH1 
gene locus 
Derivative of pFA6a‐ His3MX6 
Derivative of pCu416, expresses GFP‐tagged IDP1 from CUP1 promoter 
 
  Jiang et al., 1997 
  Jiang et al., 1997 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  Euroscarf	a 
(Gohil et al., 2005) 
  This study 
  This study 
   
Kanki et al., 2009a 
(Journo et al., 2009) 
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Table 2.2 Real-time PCR primers used in Chapter 2 
Gene Primers   Sequence 
 
 
ACT1 
 
 
 
ATG8 
                 
Forward 
                  
Reverse 
                  
Forward          
                  
Reverse 
 
TCGTGCTGTCTTCCCATCTATCG 
      
CGAATTGAGAGTTGCCCCAGAAG 
      
ACCTTACCGTAGGGCAATTTG 
     
CCCGTCCTTATCCTTGTGTTC 
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FM 4-64 and quinacrine staining 
FM 4-64 staining was performed as previously described (Conboy and Cyert, 
2000) with minor revisions. Cell aliquots equivalent to an A550 of 1.0 were harvested by 
centrifugation, resuspended in 100 μl YPD, and incubated at 37˚C or 39˚C with 0.16 
mM FM4-64 for 15 min. Cells were pelleted and washed once with 37˚C YPD or 39˚C 
YPD and then resuspended in 500 μl YPD of the same temperature for 30 min. The 
cell suspension was centrifuged and the supernatants were discarded. The cell pellets 
were resuspended in 100 μl YPD, from which 3 μl were applied to the microscope slide 
and observed using epifluorescence microscopy using the filter for red fluorescence. 
Quinacrine staining was performed as previously described (Roberts et al., 1991), 
with minor revisions. Cell aliquots equivalent to an A550 of 1.0 were harvested by 
centrifugation and resuspended in 500 μl YPD (containing 2 mM quinacrine and 
buffered to pH 7.6 with 0.5M Na2HPO4) prewarmed to 37˚C or 39˚C. After a 5 min 
incubation, cells were pelleted and washed once with 500 μl 2% glucose that had been 
buffered to pH 7.6 with 0.5M Na2HPO4. The cell suspension was pelleted again and 
resuspended in 100 μl 2% glucose at pH 7.6, from which 3 μl were applied to a 
microscope slide and observed using epifluorescence microscopy using the filter for 
green fluorescence. 
 
Detection of mitophagy using fluorescence microscopy 
Microscopic analyses were performed using an Olympus BX41 epifluorescence 
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microscope. Images were captured by an Olympus Q-Color3 digital charge-coupled 
device camera operated by QCapture2 software. All pictures were taken at a 
magnification of 1000X. To induce mitophagy, cells expressing IDH1- GFP were 
cultured in SC medium to the mid-log phase, pelleted and resuspended in 5 ml SL 
medium with a starting A550 of 0.5. They were then cultured for 18 hours and observed 
using epifluorescence microscopy. An increase in the signal of mito-GFP in the vacuole 
indicated induction of mitophagy. In addition, cells were also treated with elevated 
temperature. Both WT-IDH1-GFP and crd1Δ-IDH1-GFP were cultured in YPD medium 
to the mid-log phase at 30˚C and then switched to 39˚C for 8 hours. Cells were then 
observed using epifluorescence microscopy, using the filter for green fluorescence. 
 
Western blot 
Whole cell extracts were prepared as previously described (Kanki et al., 2009a) 
with minor changes. Cell pellets equivalent to 1.5 A550 units were collected and 
resuspended in 1 ml 10% trichloroacetic acid (TCA). Samples were incubated for 10 
min on ice and proteins were pelleted by centrifugation at 4˚C, 15,000 rpm for 10 min. 
The pellets were washed twice with 1 ml of ice-cold acetone and air-dried at room 
temperature. The air-dried cell pellets were resuspended in 75 μl sample buffer, which 
consisted of 150 mM Tris-HCl with pH 8.8, 6% SDS, 25% glycerol, 6 mM EDTA, and 
disrupted by vortexing for 3 min in the presence of 75 μl acid-washed glass beads. 
Following this step, the samples were heated at 100°C for 3 min and then centrifuged 
at 4˚C, 7,000 rpm for 30 s to pellet the glass beads. 18 μl of the supernatants that 
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contained the proteins were mixed with 6 μl 4X loading dye (80% bromophenol blue 
and 20% β-mercaptoethanol) and loaded into a 12% SDS-polyacrylamide gel for 
electrophoresis. The proteins were then transferred to a PVDF membrane with 0.2 μm 
pores following the standard semidry Western blot transfer procedure. After blotting in 
TBST-milk (TBS containing 1% TWEEN 20 and 0.5% milk), the membranes were 
incubated in TBST-milk with mouse anti-YFP monoclonal antibody (JL-8, Clontech) at 
a 1:3000 dilution at 4°C overnight. After washing with TBST (TBS containing 1% 
TWEEN 20) for 4 times, 8 min per time, the membranes were incubated in 0.5% TBST-
milk with the secondary antibody, HRP-conjugated goat anti-mouse IgG (Santa Cruz), 
at a 1:5000 dilution for 1 h at room temperature. After washing with TBST 4 more times, 
8 min per time, the membrane was covered with Pierce™ ECL Plus Western Blotting 
Substrate reagent. To detect the signal of GFP, the HyBlot ES® Autoradiography film 
was exposed to the PVDF membrane and then developed. Idh1-GFP and cleaved GFP 
were detected as bands of 68 kDa and 28 kDa, respectively. 
 
Real-Time PCR (RT-PCR) 
Both WT-IDH1-GFP and crd1Δ-IDH1-GFP strains in the FGY background were 
cultured in 10 ml YPD medium to the mid-log phase at 30˚C and then switched to 
39˚C for 8 hours. Cells were harvested and total RNA was extracted using the RNeasy 
Mini kit (QIAGEN). This procedure removed possible contaminating genomic DNA. 
cDNAs were synthesized using the Transcriptor First Strand cDNA synthesis kit 
(Roche Diagnostics) following the manufacturer’s protocol. RT-PCR was performed 
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in a 96-well plate using Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent 
Technologies). Duplicates for each sample were included. The primers used for RT-
PCR are listed in Table 2.2. ACT1 was used as the internal control. The mRNA level 
of the target gene was normalized to ACT1 mRNA levels. PCR reactions were 
performed at 95°C for 10 min for denaturation and then 40 cycles that consisted of 30 
s at 95°C and 60 s at 56°C. 
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Results 
Deletion of autophagy/mitophagy genes exacerbates the temperature 
sensitivity of crd1Δ 
Previous studies have shown that loss of CL leads to impaired mitochondrial 
function, including defective respiration (Schlame and Ren, 2006), decreased 
mitochondrial membrane potential (Jiang et al., 2000) and impaired mitochondrial 
protein import (Gebert et al., 2009; Jiang et al., 2000). It is known that mitophagy 
increases as an adaptive and protective strategy in response to damage of 
mitochondria to eliminate damaged organelles (Frank et al., 2012; Narendra et al., 
2008). A previous study in our lab found that, at elevated temperature, CL mutants 
exhibit not only growth defects but also vacuole defects characterized by enlarged 
vacuoles and loss of vacuole acidification (Chen et al., 2008b). The mechanism 
underlying the vacuole defects in the CL mutants are unknown. Because increased 
autophagy leads to a large influx of membrane and contents to the vacuole, resulting 
in increased vacuole size (Baba M et al., 1994; Baba et al., 1995; Takeshige K et al., 
1992), I originally hypothesized that loss of CL might lead to increased mitophagy to 
eliminate the damaged mitochondria at elevated temperature. In addition, my 
preliminary study found that deletion of UTH1, a gene that is involved in cell wall 
biogenesis and may play a role in mitophagy, rescued both the vacuole defects and 
the temperature sensitivity of crd1Δ (Fig. 2.1), seeming to support my hypothesis that 
the vacuole defects in the CL mutants may be due to increased mitophagy.  
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To test this hypothesis, I decided to determine if there was genetic interaction 
between CRD1 and autophagy/mitophagy genes. The rationale for this is that, 
deletion of autophagy/mitophagy genes should block excessive mitophagy and 
rescue the phenotype of crd1Δ. I constructed single mutants of mitophagy genes in 
the FGY background, including atg8Δ, atg18Δ, atg21Δ, atg32Δ, double mutants of 
crd1Δ and atg8Δ, atg18Δ, atg21Δ, atg32Δ, and the triple mutant crd1Δatg18Δatg21Δ. 
Temperature sensitivity of these strains was examined. Surprisingly, deletion of 
autophagy/mitophagy genes did not rescue (Fig. 2.2) but rather exacerbated the 
temperature sensitivity of crd1Δ (Fig. 2.3). Compared to deletion of the mitophagy-
specific gene ATG32, deletion of general autophagy genes, including ATG8 and 
ATG18, caused more severe exacerbation of crd1Δ temperature sensitivity. These 
findings suggested that mitophagy may be decreased in crd1Δ. 
 
Delivery of mitochondria to the vacuole in response to increased temperature 
is inhibited in crd1Δ  
WT-IDH1-GFP and crd1Δ-IDH1-GFP strains in the FGY background were 
constructed as described in the ‘Methods and materials’ section (Fig. 2.4). These 
strains express an endogenous Idh1 protein that is tagged with GFP at the C terminus 
and is localized in mitochondria. After culture in YPD medium to the mid-log phase at 
30˚C, WT-IDH1-GFP and crd1Δ-IDH1-GFP were switched to 39˚C for 8 hours. Cells 
were then observed using epifluorescence microscopy. Accumulation of GFP was 
observed in the vacuole of WT cells, suggesting that elevated temperature  
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GFP/Marker 
TAA Idh1 gene 
Idh1 gene GFP/Marker 
Idh1-GFP 
Marker product 
for screening 
Homologous Recombination 
Fig. 2.4 Insertion of GFP into the IDH1 gene locus. 
Strains expressing an endogenous Idh1 protein tagged 
with GFP at the C terminus were constructed as described 
in the ‘Methods and materials’ section.  
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induced delivery of Idh1-GFP tagged mitochondria into the vacuole of WT cells for 
degradation. However, translocation of crd1Δ mitochondria into the vacuole was not 
observed, suggesting that mitophagy was inhibited in crd1Δ cells (Fig. 2.5). 
A recent study reported that transcription of ATG8 positively regulates the size of 
the autophagosome (Backues et al., 2012) and reflects the extent of autophagy 
induction (Gasch et al., 2000; Kirisako et al., 1999). When autophagy is triggered, 
expression of ATG8 is induced more than 10-fold (Gasch et al., 2000; Kirisako et al., 
1999). Expression of ATG8 was determined in both WT and crd1Δ cells at 30˚C and 
after switching to 39˚C for 8 hours. ATG8 mRNA levels in WT and crd1Δ were 
comparable at 30˚C. Interestingly, ATG8 expression increased 3-fold in WT cells at 
39˚C compared to that at 30˚C, while it increased 6.7-fold in crd1Δ cells at 39˚C 
compared to that at 30˚C (Fig. 2.6). Expression of ATG8, the essential gene for 
mitophagy and non-selective autophagy, was upregulated in both WT and crd1Δ at 
elevated temperature. However, the increase was greater in crd1Δ than in WT cells, 
suggesting that, in crd1Δ, there is a greater need to initiate mitophagy, or that non-
selective autophagy may be upregulated to compensate for the decrease of mitophagy. 
 
Induction of mitophagy is inhibited in crd1Δ cells 
Based on the finding that the delivery of mitochondria into the vacuole is inhibited 
in crd1Δ compared to WT in response to elevated temperature, I predicted that 
mitophagy is decreased in crd1Δ compared to WT. Because elevated temperature has 
not been previously shown to trigger mitophagy, and mitophagy has not been studied 
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FM4-64 DIC GFP merge 
WT 
crd1Δ 
Fig. 2.5 Delivery of mitochondria to the vacuole in response to 
increased temperature is inhibited in crd1Δ. WT and crd1Δ cells 
expressing an endogenous Idh1 protein that is tagged with GFP at the 
C terminus were cultured in YPD medium to the mid-log phase at 
30˚C, shifted to 39˚C for 8 hours and observed using fluorescence 
microscopy.  
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Fig. 2.6 Increased temperature triggers increased upregulation of 
ATG8 expression in crd1Δ cells. WT and crd1Δ cells were cultured in 
YPD medium to the mid-log phase at 30˚C and divided into two groups: 
one group was kept growing in 30˚C for 8 hours while the other group 
was shifted to 39˚C for 8 hours. ATG8 expression was determined by 
RT-PCR. 
41 
 
in the FGY genetic background, I constructed WT-IDH1-GFP and crd1Δ-IDH1-GFP 
strains in the BY4742 background, which is widely used in mitophagy studies (Kanki 
et al., 2009b). WT-IDH1-GFP and crd1Δ-IDH1-GFP cells were cultured in SC medium 
to the mid-log phase at 30˚C, harvested, washed twice and resuspended in SL medium, 
which has been shown to induce mitophagy (Wu and Tu, 2011). After 18 hours, cells 
were observed using epifluorescence microscopy. Similar to the result seen in the FGY 
genetic background, accumulation of GFP was observed in the vacuole of WT but not 
crd1Δ cells, suggesting that mitophagy is inhibited in crd1Δ (Fig 2.7 A). To exclude the 
possibility that the observed differences were specific to the Idh1-GFP protein, I 
constructed WT and crd1Δ strains that have the GFP-tagged mitochondrial protein 
Idp1p exogenously expressed from the pCu416-IDP1-GFP plasmid. As seen in IDH1-
GFP strains (Fig 2.7 B), accumulation of Idp1-GFP was observed in the vacuole of the 
WT but not crd1Δ cells, suggesting that mitophagy was inhibited in crd1Δ cells. 
To confirm the microscopic finding, the release of free GFP from Idh1-GFP was 
determined in WT-IDH1-GFP and crd1Δ-IDH1-GFP strains by Western blot. Cells were 
cultured in SC medium to the mid-log phase at 30˚C, harvested, washed twice and 
resuspended in SL medium. After 5, 6 or 7 hours, proteins were extracted as described 
in the ‘Methods and materials’ section. As seen in Fig. 2.8, 6 hours after transferring to 
SL medium, a GFP band was detectable in WT cells. In contrast, the signal from crd1Δ 
cells was barely detectable. Taken together, these findings indicate that mitophagy is 
inhibited in crd1Δ. 
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crd1Δ 
DIC Idh1-GFP 
WT 
crd1Δ 
DIC Idp1-GFP 
WT 
Fig. 2.7 Decreased mitophagy in crd1Δ cells. WT and crd1Δ cells 
expressing an endogenous Idh1-GFP (A) or exogenous Idp1-GFP (B) 
were cultured in SC medium to the mid-log phase at 30˚C and shifted 
to SL for 18 hours. Cells were observed using fluorescence 
microscopy. 
A 
B 
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Idh1-GFP 
GFP 
0h    
WT crd1Δ 
5h 6h 7h 
WT crd1Δ 
 
WT crd1Δ 
 
WT crd1Δ 
Fig. 2.8 Decreased mitophagy in crd1Δ cells expressing Idh1-
GFP. WT and crd1Δ cells carrying the GFP-tagged IDH1 gene were 
pre-cultured in SC medium to the mid-log phase at 30˚C and shifted 
to SL medium for 5, 6 or 7 hours. Aliquots were taken at the indicated 
times. Immunoblotting was done with anti-YFP antibody and the 
positions of full-length Idh1-GFP and free GFP are indicated.  
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Discussion 
In this chapter, I addressed the question of how loss of CL in the crd1Δ mutant 
affects mitophagy. My findings indicate that CL deficiency leads to decreased 
mitophagy. This conclusion is based on the findings that 1) deletion of 
autophagy/mitophagy genes exacerbated crd1Δ growth defects, 2) GFP-tagged 
mitochondria were not detected in the vacuole of crd1Δ in response to mitophagy 
induction, and 3) in crd1Δ, there was decreased level of free GFP, which is cleaved 
from Idh1-GFP after the mitochondria are delivered to the vacuole for degradation in 
response to mitophagy induction. 
The finding of decreased mitophagy seemed to contradict my preliminary finding 
that deletion of UTH1 rescued both vacuole defects and temperature sensitivity in 
crd1Δ. UTH1 was first linked to mitophagy by the finding that the uth1Δ mutant was 
resistant to rapamycin, the inducer of autophagy (Camougrand et al., 2003). This was 
further supported by the report of Kissova et al. (Kissová et al., 2004), which showed 
loss of colocalization of mitochondria and vacuole in uth1Δ after rapamycin treatment. 
However, Western analysis of degradation of mitochondria as determined by free GFP 
was not carried out in this study. More recently, Uth1p was found on the mitochondrial 
inner membrane, not in the outer membrane as previously predicted, and is 
dispensable for post-log-phase and rapamycin-induced mitophagy (Welter et al., 2013). 
Based on this recent finding, rescue of crd1Δ by deletion of UTH1 is unrelated to 
mitophagy but more likely due to rescue of cell wall biogenesis defects, as CL mutants 
exhibit defects in cell wall biogenesis and in maintenance of cell integrity (Zhong et al., 
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2005). 
Interestingly, compared to deletion of the mitophagy specific gene, deletion of 
general autophagy genes that are required in both nonselective autophagy and 
mitophagy exacerbated crd1Δ growth defects to a more severe extent.  As seen in 
Fig.2.3 A, crd1Δ is synthetically lethal with atg8Δ and atg18Δ. In contrast, crd1Δ is 
synthetically sick with atg32Δ, as seen in Fig.2.3 B. The explanation for this may be 
that CL is specifically involved in mitophagy, not nonselective autophagy. Thus, 
nonselective autophagy may function normally in crd1Δ, and damaged mitochondria 
may be delivered into vacuole for degradation as cargo in the nonselective 
autophagosome. If nonselective autophagy is also blocked by deletion of ATG8 or 
ATG18, cells will not be able to get rid of damaged mitochondria, resulting in cell death. 
If mitophagy is further impaired by deletion of ATG32, damaged mitochondria may be 
eliminated by nonselective autophagy, resulting in a sick but not lethal phenotype. 
The possibility that nonselective autophagy in crd1Δ may not be compromised 
may explain the greater increase in ATG8 gene expression in crd1Δ cells compared to 
WT as seen in Fig. 2.6. Non-optimal growth temperatures likely result in a higher rate 
of formation of aberrant mitochondria and respiratory-deficient petite mutants. 
Furthermore, yeast mitochondrial protein synthesis is more thermolabile than 
cytoplasmic protein synthesis (Walker, 1998). It has been reported that exposure to 
elevated temperature induces mitochondrial swelling (Ma et al., 2004). These factors 
may account for increased ATG8 expression and mitophagy at elevated temperature 
in WT. When CL mutants are exposed to elevated temperature, mitochondrial swelling 
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may be more pronounced than in WT cells (Ma et al., 2004). Thus, it is reasonable to 
speculate that increased ATG8 expression in crd1Δ is necessary to increase 
mitophagy in order to eliminate damaged mitochondria. Another possibility is that 
crd1Δ cells upregulate nonselective autophagy to a greater extent than WT cells to 
compensate for decreased mitophagy. 
In summary, studies in this chapter suggest that loss of CL may lead to 
decreased mitophagy, which may account at least in part for the temperature sensitivity 
of the crd1Δ mutant. Previous studies indicate that the PKC and HOG MAPK pathways 
are required for mitophagy (Mao et al., 2011). To understand the underlying mechanism 
of decreased mitophagy in crd1Δ, I carried out targeted genetic interaction analysis 
between CRD1 and the genes of the MAPK pathways, which is described in Chapter 
3. The findings in this chapter provide novel insights into the cellular functions of CL 
outside of mitochondria. 
 
 
. 
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CHAPTER 3 
DEFECTIVE MITOPHAGY IN crd1Δ MAY RESULT FROM DECREASED MAPK 
PATHWAYS  
                             Introduction 
The studies described in Chapter Two suggest that perturbation of CL synthesis 
leads to defective mitophagy. Mitophagy is regulated by different pathways from those 
that control nonselective autophagy. Nonselective autophagy is regulated by at least 
four signaling pathways, including the Ras/cAMP-dependent protein kinase A (PKA) 
(Budovskaya et al., 2004; Zhou et al., 2009), the target of rapamycin (TOR) (Li et al., 
2012; Yorimitsu et al., 2007), Sch9 (Li et al., 2012; Yorimitsu et al., 2007) and Pho85 
pathways. Mitophagy is specifically regulated by two MAPK pathways: the PKC and 
HOG pathways (Li et al., 2012; Mao et al., 2011). The studies described in this chapter 
were undertaken to determine if these MAPK pathways are affected by the loss of CL, 
and if defective mitophagy in crd1Δ is due to altered PKC and HOG pathways.  
PKC is a MAPK pathway that regulates cell wall integrity in yeast. Cell wall 
integrity signaling is induced in response to various environmental stimuli, including 
heat stress, hypo-osmotic shock, mating pheromone, and agents that cause cell wall 
stress (Herskowitz, 1995; Levin and Errede, 1995). Wsc1p and Mid2p are plasma 
membrane sensors that trigger Pkc1p, which conveys the signal downstream to Bck1p, 
Mkk1p/ Mkk2p and Slt2p through a kinase cascade (Heinisch et al., 1999) (Fig. 3.1). 
In response to induction of mitophagy, Slt2p is dually phosphorylated on threonine and 
tyrosine residues (Mao et al., 2011). Deletion of the PKC pathway genes BCK1, 
MKK1/MKK2, and SLT2 leads to defective mitophagy, suggesting the involvement of 
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the PKC pathway in mitophagy. However, deletion of RLM1 and SWI4, genes encoding 
the downstream effectors of phosphorylated Slt2p (pSlt2p), does not alter mitophagy 
in WT cells. In addition, pSlt2p remains in the cytosol during mitophagy, suggesting 
that, other than conveying the signal downstream, pSlt2p may directly play a role in a 
relatively early stage of mitophagy (Fig. 3.1). As described in Chapter 2, mitophagy is 
inhibited in crd1Δ, but the mechanism underlying the inhibition is not understood. The 
finding that loss of PG, the precursor of CL, leads to defective activation of the PKC 
pathway (Zhong et al., 2007) provides a clue to the potential mechanism underlying 
inhibited mitophagy in crd1Δ. It is necessary to investigate if CL is required for PKC 
pathway activation and further regulation of mitophagy. 
The HOG pathway is a MAPK pathway that mediates the cellular response to 
osmotic stress. It consists of two stress sensing branches, SLN1 and SHO1 (Saito and 
Tatebayashi, 2004). While both branches are triggered by osmotic stress, only the 
SHO1 signaling is triggered by heat stress (Winkler et al., 2002). Sln1p and Sho1p are 
transmembrane osmosensors located within the plasma membrane. In response to 
osmotic stress, Sln1p conveys the signal downstream to Ypd1p, Ssk1p and 
Ssk2p/Ssk22p. In response to either osmotic or heat stress, Sho1p conveys the signal 
to Cdc42p, Ste20p and Ste11p/Ste50p. The MAPKKKs Ssk2p/Ssk22p and Ste11p 
trigger the same downstream MAPKK, Pbs2p. The MAPK Hog1p is dually 
phosphorylated by activated Pbs2p (Fig. 3.1). When Hog1p is phosphorylated, it 
translocates into the nucleus and induces transcription of up to 600 genes for cellular 
adaptation to stress, including the genes that function in the synthesis of glycerol 
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Fig. 3.1 The PKC and HOG pathways regulate different stages of 
mitophagy. Revised from Mao et al. 2011. 
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(O'Rourke and Herskowitz, 2004). Alternatively, phosphorylated Hog1p (pHog1p) 
remains in the cytosol under certain conditions, including high temperature and 
mitophagy induction (Mao et al., 2011; Winkler et al., 2002). Deletion of HOG1, PBS2 
and SSK1, leads to defective mitophagy, suggesting the involvement of the SLN1 
signaling of the HOG pathway in mitophagy. However, deletion of SKO1, HOT1 and 
SMP1, genes encoding the downstream effectors of pHog1p, does not alter mitophagy 
in WT cells (Mao et al., 2011). In addition, Hog1 is phosphorylated and remains in the 
cytosol after induction of mitophagy, suggesting that pHog1p may directly play a role 
in the cytosol at a relatively late stage of mitophagy (Fig. 3.1). As described in Chapter 
2, mitophagy is inhibited in crd1Δ. Thus, it is necessary to investigate if the HOG 
pathway is perturbed in crd1Δ. 
In the studies described in this chapter, I investigated the effect of CL deficiency 
on the HOG and PKC pathways. This study suggests that both pathways are defective 
when there is a loss of CL. Interestingly, upregulation of the PKC pathway rescues 
mitophagy in crd1Δ, indicating that decreased mitophagy in crd1Δ may result from an 
impaired PKC pathway.  
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Methods and materials 
Yeast strains and growth media 
The Saccharomyces cerevisiae strains used in this work are listed in Table 3.1. 
Yeast extract peptone dextrose (YPD) medium, synthetic complete (SC) medium, 
synthetic drop-out medium (SC ura-, SC leu-) and synthetic lactate (SL) medium were 
described in Chapter Two. YPDS medium was YPD medium supplemented with 1 M 
sorbitol. Sporulation medium contained potassium acetate (1%), glucose (0.05%), and 
essential amino acids. Solid medium contained agar (2%) for solidification. 
 
Construction of deletion mutants 
An established MATα crd1Δ mutant with CRD1 replaced by the dominant 
selectable marker URA3 was used as the query strain. Single mutants that have a 
single HOG pathway gene deleted were obtained from the deletion collection 
generated in the BY4741 (MATa) background (Research Genetics). The gene mutated 
in each strain was replaced by a kanamycin (geneticin) resistance marker (KanMX4). 
After crd1Δ was mated with each of these deletion strains, diploids were selected on 
SC met- lys- double drop-out medium, and sporulation was induced on sporulation 
medium. Double mutant meiotic progeny were selected on SC ura- drop-out medium 
with 200 mg/liter geneticin, as described (Tong et al., 2001). Growth of the double 
mutants was examined at various temperatures to identify genetic interactions 
between CRD1 and the HOG pathway genes. 
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Table 3.1 Yeast strains used in Chapter 3 
Strain/plasmid Characteristics or genotype             Source or reference 
BY4742 (WT)   
VGY1 (BY4742 crd1Δ) 
BY4742 sho1Δ 
VGY1sho1Δ 
BY4742 ssk1Δ 
VGY1ssk1Δ 
BY4742 ste50Δ 
VGY1ste50Δ 
BY4742 hog1Δ 
VGY1hog1Δ 
BY4742 WT‐IDH1‐GFP 
BY4742 crd1Δ- IDH1‐GFP 
 
pYPGK18 
pYPGK18‐PTP2 
pYPGK18‐PTP3 
pYCp50 
pYCp50‐PKC1 R398P 
pRS352 
pRS352‐BCK1‐20 
pPS1739‐HOG1‐GFP 
MATα, his3Δ1, leu2Δ0, lys2Δ0, ura3Δ0 
Derivative of BY4742 , crd1Δ::URA3 
Derivative of BY4742, sho1Δ:: KanMX4 
Derivative of BY4742, crd1Δ::URA3, sho1Δ::KanMX4 
Derivative of BY4742, ssk1Δ:: KanMX4 
Derivative of BY4742, crd1Δ::URA3, ssk1Δ::KanMX4 
Derivative of BY4742, ste50Δ::KanMX4 
Derivative of BY4742, crd1Δ::URA3, ste50Δ::KanMX4 
Derivative of BY4742, hog1Δ::KAN 
Derivative of BY4742, crd1Δ::URA3, hog1Δ::KanMX4 
Derivative of BY4742, in which IDH1 gene is chromosomally tagged with GFP 
Derivative of BY4742 crd1Δ::KanMX4,  in which  IDH1 gene  is chromosomally 
tagged with GFP 
2μm, LEU2 
Derivative of pYPGK18, expresses PTP2 from PGK1 promoter 
Derivative of pYPGK18, expresses PTP3 from PGK1 promoter 
CEN, URA3 
Derivative of pYCp50, expresses PKC1 R398P from PGK1 promoter 
2μm, URA3 
Derivative of pRS352, expresses BCK1‐20 from PGK1 promoter 
CEN, URA3, HOG1‐GFP 
  Euroscarf a 
(Gohil et al., 2005) 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
  This study 
 
(Vaz et al., 2003) 
  This study 
  This study 
(Helliwell et al., 1998) 
(Helliwell et al., 1998)   
(Helliwell et al., 1998) 
(Helliwell et al., 1998) 
(Ferrigno et al., 1998) 
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Plasmid construction 
To construct the PTP2 overexpression plasmid, a sequence of 2250 base pairs 
that contains the entire open reading frame of PTP2 was amplified from yeast genomic 
DNA using KpnI-tagged forward primer PTP2fr-f (5’-GG 
GGTACCATTGATGGATCGCATAGCACAG-3’) and XbaI-tagged reverse primer 
PTP2fr-r (5’- CGC TCTAGA TTAACAAGGTAACGCGTTCTTTATC -3’). After being cut 
by the restriction enzyme KpnI and XbaI, the PCR product was ligated downstream of 
the PGK1 promoter on the pYPGK18 (2um, LEU2) plasmid (Fig 3.2). 
To construct the PTP3 overexpression plasmid, a sequence of 2751 base pairs 
that contains the entire open reading frame of PTP3 was amplified from yeast genomic 
DNA using EcoRI-tagged forward primer PTP3fr-f (5’-CCGGAATTC 
GAACATGAAGGACAGTGTAGACTGC-3’) and BamHI-tagged reverse primer PTP3fr-
r (5’-CGCGGATCCGCCTAACTATTGTGGCAATTCTTTC-3’). After being cut by the 
restriction enzyme KpnI and XbaI, the PCR product was ligated downstream of the 
PGK1 promoter on the pYPGK18 (2um, LEU2) plasmid (Fig 3.2). 
 
Single colony formation and spotting 
Single colony formation experiments were performed as described in Chapter 
Two. 
Spotting experiments were performed as follows. Cells were pre-cultured in SC 
drop-out liquid medium at 30˚C to the mid-log phase. The A550 of the cells was 
determined using a spectrometer (Beckman). Cell aliquots were centrifuged and 
pellets were resuspended in SC leu- medium adjusted to an A550 of 10 units per ml. A 
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Fig. 3.2 Construction of the pYPGK18-PTP2 and pYPGK18-PTP3 
overexpression plasmids. The detailed procedure was described 
in the ‘Methods and materials’ section. 
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100X diluted sample was added onto a hemocytometer for cell counting using light 
microscopy. Based on the cell counting result, cell aliquots were adjusted to 2x108 
cells/ml. The cell aliquots were then diluted in a 10X serial dilution. Cells were spotted 
on SC drop-out plates with the most diluted spot containing 2000 cells and the plates 
were incubated at experimental temperatures for 2 days. The appearance of visible 
growth at various temperatures was evaluated. 
 
Fluorescence and microscopic analysis 
Microscopic analysis was performed using an Olympus BX41 epifluorescence 
microscope. Images were captured by an Olympus Q-Color3 digital charge-coupled 
camera operated by QCapture2 software. All pictures were taken at 1000x 
magnification.  
The method used to detect mitophagy by monitoring the translocation of GFP-
tagged mitochondria was described in Chapter Two. The same procedure was 
performed in BY4742 WT-IDH1-GFP and crd1Δ-IDH1-GFP strains that were 
transformed with either pYcp50 empty vector or pYcp50::PKC1R398, which 
overexpresses a constitutively activated Pkc1p. 
To visualize the translocation of phosphorylated Hog1p, WT and crd1Δ cells in 
the BY4742 background were transformed with the pPS1739 plasmid, which 
expresses HOG1-GFP (kindly provided by Dr. Pamela Silver, Harvard Medical School). 
Transformants were cultured in SC ura- liquid medium and grown to an A550 of 1.0. The 
cells were treated with different conditions (39°C or 0.5 M NaCl) and observed using 
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epifluorescence microscopy using a green fluorescence filter. Translocation of 
phosphorylated Hog1p was determined by the accumulation of GFP inside the nucleus. 
 
Western blot 
Western blot analysis to detect Idh1-GFP and cleaved free GFP was described 
in Chapter Two. 
To detect Slt2p and pSlt2p by Western blot, whole cell extracts were prepared 
as previously described (Hoppins et al., 2011) with minor changes. Mid-log phase cells 
were diluted to an A550 of 0.3 and grown at 30°C or 39°C. After culture at different 
temperatures for 2 hours, cells at an A550 of 1 were collected, washed with 1 ml ice-
cold sterile water and resuspended in 1 ml 0.255 M NaOH BME buffer, which consisted 
of 0.255 M NaOH, 1% β-mercaptoethanol, and 0.86 ml sterile distilled water. The 
samples were incubated for 10 min on ice and 138 μl 72% TCA were added. The 
samples were incubated on ice for another 10 min and then pelleted by centrifugation 
at 4˚C, 15000 rpm for 10 min. The pellets were washed once with 500 μl of ice-cold 
acetone, spun down at 4˚C, 15000 rpm for 5 min and then air-dried at room 
temperature. The air-dried cell pellets were resuspended in 50 μl MURB buffer, which 
consisted of 100 mM MES (PH 7.0), 1% SDS, 3 M urea, 10% β–ME and 35 μl ddH2O. 
9 μl of each sample were mixed with 3 μl 4X loading dye (80% bromophenol blue and 
20% β-mercaptoethanol) and loaded into a 10% SDS-polyacrylamide gel for 
electrophoresis. The transferring and blotting steps were described in Chapter Two. 
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The primary and secondary antibodies used to recognize dually phosphorylated pSlt2p 
and total Slt2p are listed in Table 3.2.  
To detect Hog1p and pHog1p by Western blot, whole cell extracts were prepared 
as described (Li et al., 2012). The primary and secondary antibodies used to recognize 
phosphorylated pHog1p and total Hog1p are listed in Table 3.2.  
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Table 3.2 Antibodies used in determining MAPK pathway activation 
Protein Primary Antibody Secondary Antibody     Band size 
 
pSlt2p 
 
 
 
Slt2p 
 
 
 
pHog1p 
 
 
 
Hog1p 
anti-phospho-p44/42 
MAPK (Thr202/Tyr204) 
mouse IgG  
( Cell signaling)  
                    
anti-Slt2p goat IgG 
(Santa Cruz)   
 
 
anti-phospho-p38 rabbit 
IgG (antibody 3D7; Cell 
Signaling)  
 
anti-Hog1p goat IgG 
(antibody yC-20, Santa 
Cruz) 
HRP-conjugated goat         2 bands 
anti-mouse IgG             ~ 55 kDa  
( Santa Cruz) 
      
 
HRP-conjugated donkey       1 band 
anti-goat IgG               ~ 55 kDa  
( Santa Cruz) 
 
HRP-conjugated goat          1 band 
anti-rabbit IgG              ~ 49 kDa  
( Santa Cruz) 
 
HRP-conjugated donkey       1 band 
anti-goat IgG               ~ 49 kDa  
( Santa Cruz) 
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Results 
Down-regulation of the HOG pathway exacerbates the crd1Δ growth defect. 
In Chapter Two, I reported that, under mitophagy inducing conditions, crd1Δ 
exhibited decreased mitophagy compared to WT. The HOG pathway is an upstream 
regulator of mitophagy. Deletion of the HOG pathway genes HOG1 and PBS2 leads to 
defective mitophagy (Mao et al., 2011). pHog1p appears to stay in the cytosol to play 
a role in a relatively late stage of mitophagy. Thus, I investigated the possibility that the 
HOG pathway is perturbed in crd1Δ. 
For this purpose, I determined if there is genetic interaction between CRD1 and 
HOG pathway genes. The yeast deletion collection facilitated construction of double 
mutants (Tong et al., 2001). crd1Δ was mated with sho1Δ, ssk1Δ, ste50Δ and hog1Δ 
mutants. Tetrads were obtained subsequent to sporulation, and haploids were 
acquired via tetrad dissection. Haploids containing mutations in both CRD1 and one of 
the four HOG pathway genes were selected by uracil prototrophy (crd1Δ mutation) and 
geneticin resistance (HOG pathway mutation). crd1Δ in the BY4742 background 
cannot form colonies from single cells plated on YPD at 40°C, which is a permissive 
temperature for WT (Jiang et al., 1999; Zhong et al., 2004). At 38˚C and 39˚C, crd1Δ 
cells form smaller colonies than WT. Based on this growth phenotype, genetic 
interaction was assessed at elevated temperature. Growth of double mutants at 40°C 
was considered rescue of the crd1Δ growth defect, while inability to grow at 38˚C or 
39˚C indicated exacerbation of the crd1Δ growth defect. 
While crd1Δ cells formed colonies at 39˚C, crd1Δssk1Δ did not. crd1Δste50Δ, 
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crd1Δsho1Δ, crd1Δhog1Δ did not form colonies even at 38˚C (Fig. 3.3), suggesting 
that mutants of SSK1, STE50, SHO1, and HOG1 genetically interact with crd1Δ. To 
determine if down-regulation of the HOG pathway leads to exacerbation of the crd1Δ 
growth defect, PTP2 and PTP3, which negatively regulate the HOG pathway, were 
overexpressed in crd1Δ. Serial diluted crd1Δ cells containing empty vector or 
overexpressing PTP2 or PTP3 were spotted on leu- plates and incubated at 30˚C - 
38˚C. The growth defect of crd1Δ was exacerbated by overexpression of PTP2 and 
PTP3 (Fig. 3.4). These data suggest that downregulation of the HOG pathway leads 
to exacerbation of the crd1Δ growth defect, and the HOG pathway may be perturbed 
in crd1Δ. 
 
Loss of CL leads to decreased Hog1p phosphorylation without perturbing 
activated Hog1p translocation  
Downregulation of the HOG pathway leads to exacerbation of the crd1Δ growth 
defect, suggesting that the HOG pathway may be altered in crd1Δ cells. To determine 
if Hog1p phosphorylation is perturbed in crd1Δ, I induced Hog1p activation with 0.5 M 
NaCl for 5 min, and analyzed Hog1p phosphorylation by Western blot, using a 
monoclonal antibody against dually phosphorylated p38, as described (Li et al., 2012; 
Zhou et al., 2009). Compared to WT cells, Hog1p activation was decreased in crd1Δ 
in response to osmotic stress (Fig. 3.5 A). To determine if translocation of activated 
Hog1p was perturbed in crd1Δ, WT and crd1Δ cells were transformed with the 
pPS1739 plasmid containing HOG1-GFP. The cells were cultured in SC ura- liquid  
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Fig. 3.3 Deletion of HOG pathway genes is synthetically 
lethal with CRD1 deletion. Cells were pre-cultured in liquid 
YPD at 30˚C to the mid-log phase. 200 cells of each strain 
were plated on YPD plates and incubated at 38˚C or 39˚C for 
3 days. 
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crd1Δ‐vector  crd1Δ‐PTP2 
30˚C 
36˚C 
37˚C 
38˚C 
crd1Δ‐PTP3 
Fig. 3.4 Overexpression of the negative regulators of the HOG 
pathway is synthetically lethal with CRD1 deletion. Cells were pre-
cultured in liquid SC leu- at 30˚C to the mid-log phase. Cell aliquots were 
adjusted to 2x108 cells/ml and then diluted in a 10X serial dilution. Cells 
were spotted on SC leu- plates with the most diluted spot containing 2000 
cells, and the plates were incubated at 30˚C, 36˚C, 37˚C or 38˚C for 2 
days. 
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medium to an A550 of 1 and treated with 0.5 M NaCl for 5 min. Fluorescence microscopy 
showed no difference between WT and crd1Δ in the translocation of activated Hog1p 
after NaCl treatment (Fig. 3.5 B). 
 
Heat stress does not activate Hog1p in WT and does not rescue decreased 
Hog1p phosphorylation in crd1Δ 
Both branches of the HOG pathway are triggered by activation of the 
corresponding membrane-bound sensors (Sho1p or Sln1p) in response to osmotic 
stress. A previous publication has shown that heat stress triggers the HOG pathway 
via the SHO1 but not the SLN1 signaling (Winkler A, 2002). Surprisingly, Hog1p 
phosphorylation was not observed in WT or crd1Δ in response to heat stress (Fig. 3.6 
A). The translocation of Hog1-GFP in response to heat stress was also not observed. 
WT and crd1Δ cells containing the pPS1739 plasmid were pre-cultured in liquid YPD 
at 30˚C to the mid-log phase, switched to 39˚C for 10 min and observed using 
epifluorescence microscopy. Consistent with the Western blot result, the translocation 
of Hog1-GFP into the nucleus was not observed in either WT or crd1Δ (Fig. 3.6 B), 
suggesting that heat stress does not trigger Hog1p activation or translocation in the 
BY4742 background. 
 
Upregulation of the PKC pathway rescues the crd1Δ growth defect      
As mentioned above, a previous study in yeast demonstrated that activation of 
the PKC pathway is decreased in pgs1Δ (Zhong et al., 2007). Deletion of PGS1 causes 
loss of both PG and CL. Thus, I investigated if there is decreased activation of PKC 
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A 
GFP 
DC 
WT crd1Δ 
SC ura- 30˚C 
WT crd1Δ 
SC ura- 30˚C + 0.5M NaCl 
Fig. 3.5 (A) Decreased Hog1p phosphorylation in the crd1Δ mutant. Cells 
were pre-cultured in liquid YPD at 30˚C to the mid-log phase and treated with 
0.5 M NaCl for 5 min. Dually phosphorylated Hog1p and total Hog1p protein 
were detected by Western blot, as described previously (Zhou et al., 2009). (B) 
Translocation of activated Hog1p is not affected in crd1Δ. WT and crd1Δ 
were transformed with the plasmid pPS1739, from which Hog1p fused to GFP 
was expressed. Cells were grown in SC ura- to an A550 of 1, treated with 0.5 M 
NaCl for 5 min and then observed using epifluorescence microscopy. 
B 
p-Hog1p 
0.5 M NaCl 
WT crd1Δ 
Hog1p 
WT crd1Δ 
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p-Hog1p 
WT crd1Δ WT crd1Δ 
39˚C 30˚C 
Hog1p 
A 
B 
GFP 
DC 
crd1Δ 
SC ura- 30˚C 
WT 
SC ura- 39˚C 
WT crd1Δ 
Fig. 3.6 (A) Heat stress does not trigger phosphorylation in the 
BY4742 background. Cells were pre-cultured in YPD at 30˚C to the mid-
log phase and switched to 39˚C for 5 min. Dually phosphorylated Hog1p 
and total Hog1p proteins were detected by Western blot, as described 
previously (Zhou et al., 2009).  (B) Heat stress does not induce the 
translocation of GFP tagged Hog1p into the nucleus in the BY4742 
background. WT and crd1Δ were transformed with the plasmid pPS1739, 
on which HOG1 is fused to GFP. Cells were grown in SC ura- to an A550 of 
1, switched to 39˚C, and observed using epifluorescence microscopy. 
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pathway in crd1Δ, which has PG but not CL. For this purpose, I examined the activation 
state (dual phosphorylation) of Slt2p in response to elevated temperature in isogenic 
WT, crd1Δ and pgs1Δ cells in the BY4742 background by Western blot. Because 
pgs1Δ in the FGY background requires sorbitol for survival at even 30°C, to exclude 
any influence caused by sorbitol, I also determined the Slt2p phosphorylation in pgs1Δ 
in this background, supplemented with 1 M sorbitol. Cells were pre-cultured in YPD at 
30˚C to the mid-log phase, diluted to an A550 of 0.3, and grown at 30°C or 39˚C for 2 
hours. Whole cell extracts were prepared, and dually phosphorylated Slt2p and total 
Slt2p proteins were detected by Western blot, as described in the ‘Methods and 
materials’ section. Dual phosphorylation of Slt2p in WT was detected after the cells 
were cultured for 2 hours at 39˚C. Slt2p dual phosphorylation was decreased in crd1Δ 
and almost absent in pgs1Δ and pgs1Δ supplemented with sorbitol, which indicates 
decreased PKC pathway activation in the CL mutants (Fig. 3.7 A). To upregulate the 
PKC pathway, crd1Δ was transformed with a vector expressing constitutively activated 
Bck1 (BCK1-20) or Pkc1 (PKCR398P). Consistent with the Western blot result, spotting 
experiments demonstrated that crd1Δ temperature sensitivity was rescued by plasmids 
expressing constitutively activated Bck1 or Pkc1 (Fig. 3.7 B), suggesting that 
upregulation of the PKC pathway rescues the crd1Δ growth defect.  
 
Upregulation of the PKC pathway rescues defective mitophagy in crd1Δ  
As mentioned above, activation of the PKC and HOG pathways are required for  
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mitophagy (Mao et al., 2011). Therefore, I investigated a possible causal relationship 
between decreased MAPK pathways and inhibited mitophagy in crd1Δ.  
Upregulation of the PKC pathway was achieved in WT-IDH1-GFP and crd1Δ-
IDH1- GFP strains in the BY4742 background by transfecting the cells with plasmid 
carrying the PCK1R398 gene, which encodes a constitutively activated Pkc1p. WT-
IDH1-GFP and crd1Δ-IDH1-GFP cells containing either empty vector or vector 
expressing PCK1R398 were pre-cultured in liquid SC ura- medium, harvested, washed 
twice, and resuspended in SL medium at a starting A550 of 0.5. After 18 hours, cells 
were observed using epifluorescence microscopy. As predicted, accumulation of GFP 
was observed in the vacuole of WT-IDH1-GFP cells containing either the empty vector 
or vector expressing PKC1R398P. GFP accumulation was not observed in crd1Δ-IDH1-
GFP cells containing the empty vector. Interestingly, accumulation of GFP was 
observed in crd1Δ-IDH1-GFP cells containing the vector that expresses the PKC1R398P 
gene, suggesting that mitochondria were delivered into the vacuole of this strain (Fig. 
3.8).  
The release of free GFP, a byproduct of mitophagy, was determined by Western 
blot of WT-IDH1-GFP and crd1Δ-IDH1-GFP strains containing either an empty vector 
or a vector expressing PCK1R398. Cells were cultured in liquid SC ura- medium to the 
mid-log phase at 30˚C, harvested, washed twice and resuspended in SL medium at a 
starting A550 of 0.5. After 6 hours, proteins were extracted as described previously. 
Consistent with the finding of the microscopic examination experiment, the Western 
blot showed a strong free GFP band in WT cells containing either the empty vector or  
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WT-EV WT-PKC1 crd1Δ-EV crd1Δ-PKC1 
Fig.3.8 Upregulation of the PKC pathway rescues the delivery of 
mitochondria into vacuole in crd1Δ after induction of mitophagy. 
WT-IDH1-GFP and crd1Δ-IDH1-GFP cells containing either an empty 
vector or a vector expressing PKC1R398P were cultured in SC ura- 
medium to the mid-log phase at 30˚C, washed and shifted to SL for 18 
hours. Cells were then observed with fluorescence microscopy.  
GFP 
DC 
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the vector expressing PKC1R398P, but only a very faint free GFP band in crd1Δ-IDH1-
GFP containing the empty vector, indicating that mitophagy is defective in crd1Δ cells. 
However, a strong free GFP band that is comparable to that detected in WT-ev and 
WT-PKC strains was observed in crd1Δ-IDH1-GFP cells containing  the vector that 
expresses PKC1R398P, suggesting that PKC rescued mitophagy in this strain (Fig. 3.9). 
 
The HOG pathway stimulants rescues the crd1Δ growth defect 
A constitutively activated HOG pathway causes lethality, and cannot be used to 
study mitophagy in crd1Δ. Although it is difficult to test if there is direct causal 
relationship between a decreased HOG pathway and defective mitophagy in crd1Δ, 
indirect evidence suggests that upregulating the HOG pathway may rescue the crd1Δ 
growth defect. A previous study demonstrated that the addition of 1 M sorbitol, a HOG 
pathway stimulant, rescued crd1Δ growth and vacuole defects (Chen et al., 2008b). 
Our present study established that 200 mM NaCl, another HOG pathway activator, 
similarly rescued crd1Δ temperature sensitivity (Fig. 3.10). However, more direct 
evidence is needed to conclude that a decreased HOG pathway inhibits mitophagy in 
crd1Δ. 
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0h 6h 
Idh1-GFP 
GFP 
Fig. 3.9 Upregulation of the PKC pathway rescues mitophagy in 
crd1Δ.  WT-IDH1-GFP and crd1Δ-IDH1-GFP cells containing either 
an empty vector or a vector expressing PKC1R398P were cultured in 
SC ura- medium to the mid-log phase at 30˚C, washed and shifted to 
SL. Samples were taken before shift to SL medium and at 6 hours 
post-shift. Immunoblotting was done with an anti-GFP antibody and 
the positions of full-length Idh1-GFP and free GFP are as indicated.  
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WT 
crd1Δ 
YPD+ 200 mM NaCl 
Fig. 3.10 200 mM NaCl rescues crd1Δ temperature 
sensitivity. WT and crd1Δ cells in the FGY background were 
pre-cultured in YPD liquid at 30˚C to the mid-log phase. 200 
cells were plated on a YPD plate with or without 200 mM NaCl. 
Plates were then incubated at 37.5˚C for 3 days. 
YPD 
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Discussion 
In this chapter, I addressed the hypothesis that loss of CL leads to perturbation 
of the HOG and PKC pathways, which causes defective mitophagy in crd1Δ. 
Consistent with this hypothesis, the crd1Δ mutant exhibited decreased 
phosphorylation of Hog1p in the presence of osmotic stress and decreased 
phosphorylation of Slt2p in the presence of heat stress, suggesting defective activation 
of both the HOG and PKC pathways in crd1Δ. As expected, pgs1Δ treated with heat 
stress also exhibited largely decreased phosphorylation of Slt2p. I demonstrated that 
upregulation of the PKC pathway rescued the growth defect in crd1Δ, as well as the 
accumulation of GFP labeled mitochondria and cleaved GFP in the vacuole of crd1Δ-
IDH1-GFP. This suggests that upregulation of the PKC pathway rescued mitophagy in 
crd1Δ, supporting the hypothesis that defective mitophagy in crd1Δ may be due to 
defective activation of the PKC pathway. 
Based on the previous findings that crd1Δ exhibits defective activation of the 
HOG pathway, which is required for mitophagy, upregulation of this pathway may 
rescue mitophagy in crd1Δ. However, constitutive activation of the HOG pathway 
causes cell lethality. It was previously shown that 1 M sorbitol, a HOG pathway 
stimulant, rescues the crd1Δ growth and vacuole defects (Chen et al., 2008b). In 
addition, I found that 200 mM NaCl, which also stimulates the HOG pathway, rescued 
crd1Δ temperature sensitivity (Fig. 3.8). These findings provide a clue that upregulating 
the HOG pathway may rescue the crd1Δ growth defect. However, sorbitol and NaCl 
also regulate cellular ion homeostasis, which may account for rescue of crd1Δ defects. 
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Although ion homeostasis may be perturbed in crd1Δ, it would not be the sole cause 
of the growth defect, because upregulation of the PKC pathway, which does not affect 
ion regulation, rescued the crd1Δ growth defect. 
As mentioned in Chapter Two, there was very little free GFP detected by Western 
blot in whole cell extracts from crd1Δ-IDH1-GFP after induction of mitophagy. 
Consistent with this, the phosphorylation of Slt2p and Hog1p upon induction by heat 
or osmotic stress was decreased but not fully blocked. Slt2p and Hog1p 
phosphorylation was detectable after stimulation, which might explain the faint band of 
free GFP detected in crd1Δ-IDH1-GFP cells 7 hours after mitophagy induction (Fig. 
2.8). If the HOG pathway is fully blocked, the late stage of mitophagy may be disrupted. 
Upregulation of the PKC pathway, which regulates the early stage of mitophagy, may 
not rescue mitophagy in crd1Δ under these conditions. 
Because crd1Δ is synthetically lethal with mutants of SLN1 and SHO1 branches, 
decreased activation of both branches may occur in crd1Δ. To address this possibility, 
Hog1p activation in double mutants with deletion of CRD1 and a gene from either 
branch should be compared to that of crd1Δ. For example, if sho1Δ exacerbates the 
Hog1p activation defect in crd1Δ, this would suggest that CL may be required for 
activation of SLN1 signaling. 
Translocation of pHog1p into the nucleus was not affected in crd1Δ cells. 
Surprisingly, elevated temperature did not induce phosphorylation or the translocation 
of Hog1p into the nucleus. This conflicts with the finding of Winkler, who reported that 
heat stress induced Hog1p activation (Winkler et al., 2002), but it may be explained by 
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the fact that our studies were performed using strains from different backgrounds. Heat 
activation of the HOG pathway is likely to be strain dependent. 
In summary, the studies described in this chapter suggest that the loss of CL may 
lead to decreased PKC and HOG pathways, and that a defective PKC pathway may 
account for impaired mitophagy in the crd1Δ mutant. The findings in this chapter 
provide novel insights into the cellular function of CL. It is tempting to speculate that 
upregulation of the PKC pathway may be a potential treatment strategy for BTHS 
patients.  
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CHAPTER 4 
 
 
FUTURE DIRECTIONS 
  
The studies described in this thesis provide novel insights into the cellular 
functions of CL beyond the confines of mitochondria, including mitophagy and the PKC 
and HOG pathways. While my studies showed that loss of CL leads to defective 
mitophagy, which may be due to decreased function of MAPK pathways, much remains 
to be unveiled. To elucidate the mechanism linking defective mitophagy and MAPK 
pathways in CL-deficient cells, as well as the mechanism underlying the role of CL in 
vacuolar morphology and acidification, future studies should address the following 
questions: 
 
1. Does nonselective autophagy function normally in crd1Δ ? 
In Chapter 2, I showed that CL deficiency leads to decreased levels of 
mitochondria and cleaved GFP in the vacuole, suggesting defective mitophagy in 
crd1Δ cells. However, deletion of ATG8 or ATG18, the general autophagy genes 
required for both nonselective autophagy and mitophagy, exacerbated the crd1Δ 
growth defect to a greater extent than deletion of the mitophagy specific gene, ATG32, 
(Fig. 2.3). I hypothesize that CL is specifically required for mitophagy, not for 
nonselective autophagy. Accordingly, if nonselective autophagy is unaffected in crd1Δ, 
damaged mitochondria can be enclosed in nonselective autophagosomes and 
delivered to the vacuole for degradation. However, if nonselective autophagy in crd1Δ 
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is blocked by deletion of ATG8 or ATG18, the cell will not be able to remove damaged 
mitochondria. This would result in cell death, consistent with synthetic lethality of crd1Δ 
and atg8Δ. This hypothesis is further supported by the finding that expression of ATG8 
in crd1Δ is two-fold higher than in WT at 39˚C (Fig. 2.6), suggesting that nonselective 
autophagy is upregulated in crd1Δ.   
If nonselective autophagy is functional in crd1Δ cells, stimulation by rapamycin 
might be expected to rescue crd1Δ growth defects. To test this possibility, rapamycin 
was added to YPD plates and temperature sensitivity of crd1Δ and WT in the FGY 
background was examined at 36.5°C and 37°C. WT cells were unable to grow at 
elevated temperature in the presence of rapamycin concentrations greater than 1 nM. 
0.01-1 nM rapamycin did permit growth of WT cells, while 0.5 nM rapamycin induced 
a slight rescue of crd1Δ temperature sensitivity at elevated temperature (data not 
shown). Future experiments are necessary to explain why only 0.5 nM rapamycin 
rescued crd1Δ growth defects. Rapamycin is an antifungal antibiotic, which inhibits the 
target of rapamycin complex 1 (TOR1). In addition to negatively regulating autophagy 
and transcription of stress responsive genes, TOR1 positively regulates ribosome 
biogenesis, global translation initiation, and nutrient import. Thus, the effect of 
rapamycin is like a double-edged sword: it increases autophagy while inhibiting 
ribosome biogenesis, global translation initiation, and nutrient import, resulting in cell 
lethality.  With additional growth defects, crd1Δ may be more sensitive to rapamycin 
than WT. The toxicity of 0.5-1 nM rapamycin may overwhelm the benefits of increased 
nonselective autophagy induced by these concentrations in crd1Δ. crd1Δ may tolerate 
78 
 
rapamycin less than 0.5 nM. However, levels of nonselective autophagy triggered by 
these concentrations may be inadequate to remove the majority of damaged 
mitochondria. 0.5 nM rapamycin may be an optimal concentration that can trigger 
enough nonselective autophagy to remove the majority of the damaged mitochondria. 
To definitively ascertain if nonselective autophagy is functional in CL deficient 
cells, direct monitoring of nonselective autophagy in crd1Δ is required. An engineered 
protein Pho8Δ60 has been designed for this purpose (Noda and Klionsky, 2008). 
Pho8Δ60 lacks the N-terminal transmembrane domain of Pho8 (alkaline phosphatase) 
that targets the endoplasmic reticulum; thus, the mutated protein remains in the cytosol 
and is only delivered to the vacuole through nonspecific autophagy. After entering the 
vacuole lumen, the alkaline phosphatase activity of Pho8Δ60 is proteolytically 
activated. Therefore, enzyme activity of Pho8Δ60 reflects the level of nonspecific 
autophagy. To determine if nonselective autophagy is upregulated to compensate for 
defective mitophagy in crd1Δ cells, the Pho8Δ60 assay should be performed.  
 
2. Which branch of the HOG pathway is defective in crd1Δ? 
As described in Chapter 3, loss of CL leads to decreased Hog1p phosphorylation 
without perturbing activated Hog1p translocation. However, it is not known if decreased 
Hog1p phosphorylation is due to perturbation of the SHO1 or SLN1 branch, or perhaps 
to both.  
If loss of CL leads to defective SHO1 signaling, downregulating SLN1 signaling 
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will exacerbate decreased Hog1p activation in crd1Δ. In this situation, with 0.5 M NaCl, 
crd1Δssk1Δ (SSK1 is required for SLN1 signaling) should have less Hog1p activation 
than crd1Δ, while crd1Δsho1Δ should have comparable Hog1p activation with crd1Δ. 
If loss of CL leads to defective SLN1 signaling, downregulating SHO1 signaling will 
exacerbate the decreased Hog1p activation in crd1Δ. In this situation, with 0.5 M NaCl, 
crd1Δsho1Δ should have less Hog1p activation than crd1Δ, while crd1Δssk1Δ should 
have comparable Hog1p activation with crd1Δ. However, if CL is required for activation 
of both branches, then the Hog1p activation in both crd1Δsho1Δ and crd1Δssk1Δ will 
be less than that of crd1Δ. 
In summary, comparing Hog1p activation in crd1Δ, crd1Δsho1Δ and crd1Δssk1Δ 
by Western blot should help to identify which HOG branch is defective in crd1Δ.  
 
3.   How does sorbitol rescue crd1Δ growth and vacuole defects?  
A previous study in our lab showed that 1 M sorbitol restores both growth and 
vacuole defects in crd1Δ by a mechanism not yet identified (Chen et al., 2008b). As 
shown in Fig. 4.1, 1 M sorbitol upregulates the HOG pathway at 39˚C, which might be 
the mechanism underlying rescue of crd1Δ temperature sensitivity and vacuole defects 
by sorbitol. However, the possibility that 1 M sorbitol restores the defects of crd1Δ via 
stimulating other osmotic regulatory pathways is not excluded. To address this 
question, my previous labmate Shuliang Chen and I carried out a targeted screen of 
osmotic regulatory mutants to identify those that abrogated sorbitol-mediated rescue 
of crd1Δ. Double mutants of CRD1 and the genes shown in Table 4.1 were constructed.  
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WT crd1Δ 
YPD 
WT   crd1Δ WT   crd1Δ 
1M sorbitol 0.5 M NaCl 
    p-Hog1p 
   Hog1p 
   39˚C 
Fig. 4.1 1 M sorbitol induces Hog1p activation in crd1Δ at elevated 
temperature. Cells were pre-cultured in YPD at 30˚C to mid-log phase 
and switched to 39˚C for 5 min and at the same time treated with either 
0.5 M NaCl (positive control) or 1 M sorbitol. The dually phosphorylated 
Hog1p and total Hog1p proteins were detected by Western blot, as 
described previously (Zhou et al., 2009).   
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Failure of sorbitol to rescue the double mutant indicated that the query gene is required 
for sorbitol-mediated rescue of crd1Δ.  
A search of the Saccharomyces Genome Database identified 57 nonessential  
genes that are involved in the HOG or other osmotic stress pathways (Table 4.1). A 
targeted synthetic genetic array (SGA) was performed as described (Zhou et al., 2009). 
Single mutants of the stress response genes were mated with crd1Δ, diploids were 
sporulated, and progeny containing mutations in both CRD1 and each of the query 
genes were selected by geneticin resistance (mutation of the query gene) and uracil 
prototrophy (CRD1 mutation). Double mutants were confirmed by PCR. 
Four of the double mutants were tested, including crd1Δanp1Δ, crd1Δptc7Δ, 
crd1Δosm1Δ and crd1Δdog2Δ. All were rescued by 1 M sorbitol at elevated 
temperature (Fig.4.2). This indicates that the corresponding genes are not required for 
sorbitol rescue. 53 double mutants remain to be tested. The screen for double mutants 
that cannot grow on YPD or YPD supplemented with 1 M sorbitol at elevated 
temperature is an interesting direction to pursue in future studies. 
 
4. What is the mechanism underlying the vacuole defects in crd1Δ ? 
A previous study in our lab found that, at elevated temperature, CL mutants 
exhibit enlarged vacuoles and loss of vacuole acidification (Chen et al., 2008b). The 
observed decrease in V-ATPase activity and proton pumping in crd1Δ may explain the 
loss of acidification of the vacuole. However, the mechanism underlying the enlarged 
vacuole morphology remains unknown. The following studies aimed to address the  
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Table 4.1. Deletion strains used in the mini SGA 
Standard name Standard name  Standard name 
 
YHR078W 
 
HKR1 
 
NBP2 
 
GRE1 
 
PTC1 
 
IZH2 
 
OSM1 
 
ANP1 
 
MSN1 
 
GLO1 
 
RVS161 
 
SKN7 
 
STE50 
 
SHO1 
 
MPC3 
 
PCK2 
 
SIP18 
 
SMP1 
 
SKO1 
 
SSK2 
 
VAC7 
 
PTC2 
 
PBS2 
 
GRE2 
 
SSK1 
 
NHX1 
 
FIG4 
 
GON7 
 
GRE3 
 
GPD1 
 
YNL190W 
 
PAI3 
 
AGP2 
 
PTP3 
 
PTP2 
 
HIR1 
 
RRD2 
 
YJL144W 
 
POR1 
 
YPR1 
 
PTC7 
 
HSP12 
 
PPZ2 
 
PPZ1 
 
YML131W 
 
PTC3 
 
ZNF1 
 
DOG2 
 
MSB2 
 
POR2 
 
HOT1 
 
AQY2 
 
RVS167 
 
STE11 
 
YAR1 
 
STL1 
 
GPP1 
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crd1Δ crd1Δosm1Δ crd1Δptc7Δ crd1Δanp1Δ crd1Δdog2Δ 
YPDS 
YPD 
Fig. 4.2 Deletion of ANP1, PTC7, OSM1 or DOG2 does not 
abrogate the rescue of crd1Δ temperature sensitivity by 
sorbitol. Cells were pre-cultured in liquid YPD at 30˚C to the 
mid-log phase. Approximately 200 cells of each strain were 
plated on YPD or YPDS plates and incubated at 39.5°C for 3 
days. 
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potential mechanism of vacuole morphology defects in crd1Δ. 
 
4.1 Increased nonselective autophagy may not be the cause of vacuole 
enlargement 
As described in Chapter 2, elevated temperature triggers increased expression 
of the general autophagy gene, ATG8, in both crd1Δ and WT (Fig. 2.6). In addition, at 
39°C, ATG8 expression is two-fold greater in crd1Δ than in WT. Although mitophagy is 
defective in crd1Δ, nonselective autophagy may not be affected, as discussed in 
Chapter 2. Because autophagy is the source of a large influx of lipid membrane and 
cellular contents to the vacuole (Baba M et al., 1994; Baba et al., 1995; Takeshige K 
et al., 1992), it is reasonable to speculate that increased nonselective autophagy may 
be the cause of vacuole enlargement in crd1Δ. 
If enlargement of the vacuole in crd1Δ at elevated temperature is due to 
increased nonselective autophagy, deletion of the nonselective autophagy genes 
should rescue the vacuole morphology defect of crd1Δ. To address this possibility, the 
effect of deleting nonselective autophagy genes on vacuole morphology of crd1Δ cells 
was determined. As seen in Fig. 4.3, crd1Δatg8Δ exhibited enlarged vacuoles similar 
to crd1Δ, indicating that blocking nonselective autophagy does not rescue the vacuole 
enlargement triggered by elevated temperature in crd1Δ. 
In addition, if increased nonselective autophagy causes vacuole enlargement, 
triggering nonselective autophagy should lead to enlarged vacuoles in WT and crd1Δ 
at optimal temperature. To address this hypothesis, rapamycin, a stimulant of  
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WT atg8Δ crd1Δ crd1Δatg8Δ 
FM4-64 
DIC 
Fig. 4.3 Deletion of ATG8 does not rescue the vacuole 
enlargement triggered by elevated temperature in crd1Δ. 
Cells were pre-cultured at 30 ℃ to the early log phase and 
then transferred to 37℃  at a starting A550 of 0.5 for 8h. FM4-
64 staining was performed and cells were observed using 
fluorescence microscopy for vacuole morphology. 
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nonselective autophagy, was used to trigger nonselective autophagy in WT and crd1Δ 
at 30°C. FM 4-64 staining was performed to observe vacuole morphology. As seen in 
Fig. 4.4, both crd1Δ and WT exhibited enlarged vacuoles, raising the possibility that 
nonselective autophagy triggered by rapamycin results in enlarged vacuoles in even 
WT. However, rapamycin has downstream effects other than autophagy. If the vacuole 
enlargement triggered by rapamycin in crd1Δ and WT was due to increased 
nonselective autophagy, but not to other downstream effects of rapamycin, deletion of 
the nonselective autophagy genes in these strains should rescue vacuole morphology. 
However, with rapamycin, atg8Δ and crd1Δatg8Δ exhibited enlarged vacuoles similar 
to that in crd1Δ and WT, indicating that blocking autophagy does not rescue vacuole 
enlargement triggered by rapamycin. Thus, the vacuole enlargement induced by 
rapamycin is probably not due to increased nonselective autophagy. In addition to 
triggering nonselective autophagy via the TOR1 pathway (Li et al., 2012; Yorimitsu et 
al., 2007), rapamycin may be involved in other cellular processes that regulate vacuole 
size. 
 
4.2 Is the vacuole defect caused by perturbation of the FAB pathway in crd1Δ ? 
The FAB pathway regulates the synthesis of phosphatidylinositol 3-phosphate 
(PI3P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), which affects the size 
and acidification of the vacuole. Interestingly, the fab1Δ mutant, in which PI(3,5)P2 is 
undetectable, displays growth and vacuole defects that are similar to those in crd1Δ, 
including decreased growth at elevated temperature, vacuole enlargement and loss of  
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WT atg8Δ crd1Δ crd1Δatg8Δ 
FM4-64 
DIC 
Fig. 4.4 Rapamycin triggers enlargement of vacuoles in both WT 
and crd1Δ, which is not rescued by deletion of ATG8. Cells were 
pre-cultured at 30 ℃ to the early log phase and then transferred to 
medium containing 10nM rapamycin at a starting A550 of 0.5 for 8h. 
FM4-64 staining was performed and cells were observed using 
fluorescence microscopy for vacuole morphology.   
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vacuole acidification (Bonangelino et al., 2002; Gary et al., 1998; Yamamoto et al., 
1995). Thus, Chen et al. suggested that perturbation of the FAB pathway in CL 
deficient cells may explain the vacuole defects. Chen determined that mRNA levels of 
the FAB pathway genes were not affected in crd1Δ cells (Chen et al., 2008b). However, 
FAB1 is not transcriptionally regulated (Gary et al., 1998). Therefore, non-
transcriptional regulation of the FAB pathway may be defective in crd1Δ. Further 
studies are necessary to address this possibility. 
 
4.2.1 The FAB pathway 
As shown in Fig. 4.5, the first step of the FAB pathway is the synthesis of PI3P 
from PI, catalyzed by phosphatidylinositol (PI) 3-kinase, Vps34p (Auger et al., 1989; 
Slessareva et al., 2006). Fab1p, which localizes to the vacuole membrane, catalyzes 
the second step, converting vacuolar PI3P to PI(3,5)P2 (Dove et al., 2002; Gary et al., 
1998; Yamamoto et al., 1995). The reverse reaction to dephosphorylate PI(3,5)P2 to 
PI3P is catalyzed by PI(3,5)P2 phosphatase, Fig4p (Rudge et al., 2004), which is also 
needed for maximum function of Fab1p (Duex et al., 2006). Fab1p can be activated by 
Vac7p and Vac14p (Bonangelino et al., 1997; Duex et al., 2006; Gary et al., 2002), the 
latter of which is physically associated with Fig4p (Duex et al., 2006). Atg18p 
negatively regulates Vac7p (Efe et al., 2005). This regulatory pathway controls levels 
of PI(3,5)P2, which affect vacuole size and acidification. It is known that hyperosmotic 
stress leads to increased PI(3,5)P2, resulting in shrunken and fragmented vacuoles 
(Bonangelino et al., 2002; Dove et al., 1997), while loss of PI(3,5)P2 by deletion of  
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Fig. 4.5 The FAB pathway and its regulation. Revised from 
Efe et al., 2005.  
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FAB1 leads to enlarged vacuoles (Gary et al., 1998; Odorizzi et al., 1998). 
 
4.2.2 Is the FAB pathway perturbed in crd1Δ ? 
To determine if there is perturbation of the FAB pathway in crd1Δ, I assessed 
genetic interaction between crd1Δ and fig4Δ, because Fig4p is essential for both 
synthesis and turn over of PI(3,5)P2. If the FAB pathway in crd1Δ is perturbed, no 
matter whether there is altered synthesis of PI(3,5)P2, or altered turn-over of PI(3,5)P2, 
I should see genetic interaction between FIG4 and CRD1. The ability of single cells to 
form colonies was observed, using our lab generated crd1Δfig4Δ, fig4Δ, crd1Δ and WT 
strains in the FGY background. As shown in Fig. 4.6, deletion of FIG4 partially rescued 
the crd1Δ growth defect at 37.5°C, suggesting that the FAB pathway may be perturbed 
in crd1Δ. Levels of PI(3,5)P2 may be decreased, and deletion of FIG4 may rescue the 
growth defects of crd1Δ by blocking the dephosphorylation of PI(3,5)P2.  
 
4.2.3  PI3P and PI(3,5)P2 are localized normally on the vacuole membrane of crd1Δ. 
The findings described in section 4.2.2 provided a clue that the growth and 
vacuole defects in crd1Δ may be due to perturbation of the FAB pathway. Thus, it was 
necessary to determine if PI3P and PI(3,5)P2 on the vacuole membrane of crd1Δ are 
decreased. 
To directly observe if there is loss of PI3P or PI(3,5)P2 on the vacuole membrane, 
both crd1Δ and WT cells were transformed with the pRS415-GFP-FYVE and pRS415-
GFP-ATG18 plasmids (kindly provided by Rania Deranieh), while fab1Δ containing the  
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crd1Δ  
crd1Δfig4Δ fig4Δ 
WT 
Fig. 4.6 Deletion of FIG4 partially rescues crd1Δ 
temperature sensitivity. Cells were pre-cultured in liquid 
YPD at 30˚C to the mid-log phase. Approximately 200 cells of 
each strain were plated on YPD plates and incubated at 
37.5°C for 3 days. 
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pRS415-GFP-ATG18 plasmid (kindly provided by Rania Deranieh) was used as a 
negative control. The pRS415-GFP-FYVE plasmid expresses a protein in which GFP 
is fused to the FYVE zinc finger domain. Binding of the FYVE domain of this probe to 
PI3P enables the monitoring of PI3P intracellular localization. The pRS415-GFP-
ATG18 plasmid expresses a PI(3,5)P2 specific fluorescent lipid-associated reporter 
(FLARE), on which GFP is fused to the PI(3,5)P2 binding domain of Atg18p. At elevated 
temperature, PI3P and PI(3,5)P2 vacuolar localization in crd1Δ was similar to that of 
WT (Fig 4.7). In contrast, there is a loss of PI(3,5)P2 on the vacuole membrane in fab1Δ 
(Fig 4.8), suggesting that loss of vacuolar PI(3,5)P2 may be the cause of the vacuole 
defects in fab1Δ but not crd1Δ. However, normal PI3P and PI(3,5)P2 vacuole 
localization does not exclude the possibility that PI(3,5)P2 levels are slightly decreased 
in crd1Δ, which would not be discernible by comparison of fluorescence intensity. 
Analysis of PI3P and PI(3,5)P2 levels by HPLC would be required to conclusively show 
altered FAB pathway function. 
 
4.2.4 Are protein levels of the FAB pathway regulators altered in crd1Δ ? 
Although overexpression of FAB1 did not increase PI(3,5)P2 levels (Gary et al., 
1998), overexpression of FAB1 suppressed the vacuole defects in vac14Δ (Dove et 
al., 2002). This finding suggests that, other than regulating synthesis of PI(3,5)P2, 
Fab1p also directly controls vacuole size and acidification by a mechanism still unkown. 
Thus, the protein levels of the FAB pathway regulators are also important for vacuole 
morphology and acidification. Although Chen showed that the mRNA levels of FAB1,  
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WT crd1Δ 
Fig. 4.7 crd1Δ exhibits normal PI3P localization at the vacuolar 
membrane. Cells were pre-cultured at 30 ℃  to the early log 
phase and then transferred to 37℃  at a starting A550 of 0.5 for 8h. 
PI3P localization was then observed using fluorescence 
microscopy.   
GFP 
Phase Contrast 
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WT crd1Δ fab1Δ 
Fig. 4.8 Normal vacuolar localization of PI(3,5)P2 in crd1Δ. 
Cells were pre-cultured at 30℃ to the early log phase and then 
transferred to 37℃  at a starting A550 of 0.5 for 8h. Cells were 
then observed using fluorescence microscopy to determine 
PI(3,5)P2 localization. 
Phase Contrast 
GFP 
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VAC7, VAC14, VPS15, VPS34, FIG4, and ATG18 were not affected in crd1Δ cells, the 
protein levels were not examined (Chen et al., 2008b). 
The optimal way to address this question is to detect the protein levels of these 
regulators by Western blot. However, primary antibodies against these proteins are not 
commercially available. Thus, I employed an indirect approach to address this question. 
If overexpression of FAB1 or VAC7 suppresses the vacuole defects in crd1Δ, it 
suggests that Fab1p or Vac7p protein levels may be decreased in the mutant, which 
may account for the vacuole defects. crd1Δ in the BY4742 background was 
transformed with vectors expressing either FAB1 or VAC7  (or empty pYPGK18 
vector as a negative control), plated on leu- plates, and incubated at 30⁰C or 38⁰C. The 
ability of single cells to form colonies was observed. Overexpression of FAB1 and 
VAC7 in crd1Δ did not rescue the growth defects of crd1Δ (Fig 4.9), indicating that 
Fab1p and Vac7p protein levels may be unaltered in crd1Δ. However, it is possible 
that there is targeted degradation of the FAB1 and VAC7 mRNA in crd1Δ, resulting in 
not only degradation of endogenous FAB1 and VAC7 mRNA, but also FAB1 and VAC7 
mRNA that is expressed from the overexpression vector. 
To definitively ascertain if protein levels of FAB pathway regulators are altered in 
CL deficient cells, Western blot detections of these proteins are required. Because the 
primary antibodies against these proteins are not commercially available, an 
alternative approach is to tag each FAB pathway regulator with the hemagglutinin (HA) 
tag to enable the detection of these proteins by Western blot.  
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38℃ 30℃ 
crd1Δ-vec 
crd1Δ-FAB1 
crd1Δ-VAC7 
Fig. 4.9 Overexpression of FAB1 and VAC7 does not rescue crd1Δ 
temperature sensitivity. Cells were pre-cultured in liquid SC leu- at 
30˚C to the mid-log phase. Approximately 200 cells of each strain were 
plated on SC leu- plates and incubated at 38°C for 3 days. 
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4.3 Are the vacuole defects in crd1Δ caused by perturbation of the Ena1 Na+-
ATPase exporter? 
Vacuole size and acidification are regulated by PI(3,5)P2, as well as ion pumps 
and channels presented in the vacuole membrane. These include the H+-Ca2+ 
exchanger Vcx1p, the Ca2+ pump Pmc1p, the Ca2+ channel Yvc1p, the H+-Na+ 
exchanger Nhx1p, and the voltage-sensitive Cl– channel Gef1p (Bonilla and 
Cunningham, 2002; Ke et al., 2013; Li and Kane, 2009). Deletion of NHX1, but not the 
genes encoding the other pumps or channels, suppresses vacuole defects and 
temperature sensitivity of crd1Δ (Chen et al., 2008b). There is defective vacuolar V-
ATPase activity and reduced proton transport in crd1Δ, causing decreased intra-
vacuolar H+ levels (Chen et al., 2008b). Deletion of NHX1 blocks the vacuolar efflux of 
H+ and influx of Na+, which may counteract the decreased vacuolar H+ level. However, 
the mechanism whereby deletion of NHX1 rescues the vacuole morphology remains 
to be elucidated. 
Because deletion of NHX1 blocks the influx of Na+ into the vacuole, it is 
reasonable to speculate that there may be excessive Na+ in the vacuole of crd1Δ. Na+ 
is sequestered in the vacuole when intracellular Na+ levels are increased (Li et al., 
2012). If there is excessive intra-vacuolar Na+ in crd1Δ, it may indicate increased 
intracellular Na+ in this strain. 
The amount of intracellular Na+ in Saccharomyces cerevisiae is tightly regulated 
by activity of the ion pumps and channels on the cell membrane. The cell membrane 
influx of Na+ is mainly induced by the Na+-K+ transporter Trk system and the non-
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specific cation channel Nsc1. Conversely, the efflux of Na+ is induced by the Na+/K+-
ATPase Ena1p and the Na+, K+/H+ antiporter Nha1p (Ke et al., 2013). Although Ena1p 
and Nha1p are both involved in cell Na+ efflux, Nha1p plays a larger role in K+ extrusion 
and cell survival under acidic conditions, while Ena1p is more involved in Na+ extrusion 
and cell survival under alkaline conditions (Jung et al., 2012). In WT cells, heat shock 
stimulates activity of the Na+-K+ pump (the Trk system) without affecting intracellular 
Na+ levels (Boonstra et al., 1984), suggesting that the efflux of Na+ may be upregulated 
to counteract stimulation of the Na+-K+ pump at elevated temperature. Thus, Na+ efflux 
is essential for cell survival under heat stress. 
 
4.3.1  Deletion of ENA1 does not exacerbate crd1Δ temperature sensitivity 
I hypothesized that Na+ efflux is defective in crd1Δ at 39˚C, resulting in increased 
intracellular Na+. To alleviate toxicity caused by increased intracellular Na+, vacuolar 
Na+ influx is increased, resulting in increased osmotic pressure and vacuole 
enlargement. To test my hypothesis, I investigated if there is genetic interaction 
between CRD1 and ENA1, which encodes the major Na+ efflux transporter. Synthetic 
lethality would suggest that Ena1p is defective in crd1Δ. A crd1Δena1Δ double mutant 
was constructed by tetrad dissection and examined for temperature sensitivity. 
Deletion of ENA1 did not exacerbate crd1Δ temperature sensitivity (Fig. 4.10), 
suggesting that Ena1p may not be defective in crd1Δ. 
 
4.3.2  Upregulation of ENA1 expression may be partially impaired in crd1Δ 
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crd1Δ 
ena1Δ 
crd1Δena1Δ 
WT 
crd1Δ 
ena1Δ 
crd1Δena1Δ 
Fig. 4.10 Deletion of ENA1 does not affect crd1Δ 
temperature sensitivity. Cells were pre-cultured in 
liquid YPD at 30˚C to the mid-log phase. Aliquots were 
adjusted to 2x108 cells/ml and then diluted in a 10X 
serial dilution. Cells were spotted on YPD plates with 
the most diluted spot containing 2000 cells, and the 
plates were incubated at 30˚C or 39˚C for 2 days. 
39˚C 
30˚C 
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Ena1p is regulated at the transcriptional level (Ke et al., 2013; Márquez JA and 
R., 1996; Platara et al., 2006). To determine if there is defective Na+ efflux in crd1Δ at 
39˚C, it is necessary to determine if ENA1 gene expression is decreased in crd1Δ 
compared to WT at 39˚C. This would suggest that Na+ efflux will be decreased, leading 
to increased intracellular Na+. WT and crd1Δ cells were incubated at either 30˚C or 
39˚C for 2 hours. ENA1 expression in these strains was determined by RT-PCR. At 
39˚C, ENA1 expression was upregulated in both WT and crd1Δ.  However, 
upregulation of ENA1 expression in crd1Δ was less than in WT (Fig. 4.11), suggesting 
that upregulation of ENA1 expression may be partially impaired in crd1Δ at elevated 
temperature. Impaired ENA1 upregulation may lead to inadequate Na+ efflux and 
accumulation of intracellular Na+, leading to vacuole enlargement.  
 
4.3.3  Overexpression of ENA1 does not rescue crd1Δ temperature sensitivity 
As seen in Fig.4.11, there may be impaired upregulation of ENA1 in crd1Δ at 
39˚C. I then determined if overexpression of ENA1 rescues crd1Δ. crd1Δ was 
transformed with a vector (pYPGK18) overexpressing ENA1, spotted on the leu- plates 
and incubated at 30˚C or 39˚C. Overexpression of ENA1 did not affect crd1Δ 
temperature sensitivity (Fig. 4.12), indicating that the growth and vacuole defects in 
crd1Δ at elevated temperature are probably not due to impaired upregulation of ENA1 
in crd1Δ. 
The findings in Section 4.3.2 and 4.3.3 are controversial. To conclusively address 
if there is increased intracellular Na+, the total Na+ level in crd1Δ at 39˚C should be  
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crd1Δ 39˚C crd1Δ 30˚C WT 30˚C WT 39˚C 
Fig. 4.11 Inadequate ENA1 upregulation in crd1Δ 
compared to WT, at elevated temperature. WT and 
crd1Δ cells were cultured in YPD medium to the mid-log 
phase at 30˚C and then incubated at either 30˚C or 39˚C 
for 2 hours. ENA1 expression was determined by RT-PCR. 
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crd1Δ + 
ENA1 
vec 
crd1Δ + 
ENA1 
vec 
39˚C 
30˚C 
Fig. 4.12 Overexpression of ENA1 does not rescue 
crd1Δ temperature sensitivity. Cells were pre-
cultured in liquid SC leu- at 30˚C to the mid-log phase. 
Aliquots were adjusted to 2x108 cells/ml and then 
diluted in a 10X serial dilution. Cells were spotted on 
YPD plates with the most diluted spot containing 2000 
cells, and the plates were incubated at 30˚C or 39˚C 
for 2 days. 
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directly measured by isotachophoresis (Nakamura et al., 1993), an analytical 
chemistry technique used for quantification of ionic analytes. 
 
5. Summary 
In this chapter, I suggest future experiments to elucidate how CL regulates 
mitophagy and MAPK pathways. In addition, experiments to investigate the role of CL 
in vacuole homeostasis were described, and future directions related to this work have 
been proposed. Much about CL remains to be elucidated. I encourage my junior 
labmates to continue to explore the mystery of how CL contributes to human life and 
health. 
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Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, is 
important for cardiovascular health. Perturbation of CL metabolism is implicated in 
cardiovascular disease (CVD). The link between CL and CVD may be explained by the 
physiological roles of CL in pathways that are cardioprotective, such as 
autophagy/mitophagy and the mitogen-activated protein kinase (MAPK) pathways. My 
dissertation work focuses on elucidating how CL influences mitophagy and MAPK 
pathways. 
crd1Δ was synthetically lethal/sick with the general autophagy mutants atg8Δ, 
atg18Δ and mitophagy mutant atg32Δ, suggesting that autophagy/mitophagy may be 
deficient in cells lacking CL. Microscopic examination of mitophagy revealed 
decreased translocation of GFP-tagged mitochondrial proteins into the vacuole of 
crd1Δ cells. This was confirmed by a decreased level of free GFP generated by 
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cleavage of GFP-tagged mitochondrial protein after delivery into the vacuole by 
mitophagy. These findings indicated that mitophagy is decreased in CL-deficient cells. 
Expression of ATG8 was increased in crd1Δ cells at 37˚C, suggesting that nonselective 
autophagy was upregulated to compensate for decreased mitophagy. 
The PKC and HOG MAPK pathways are known to be required for mitophagy. 
crd1Δ growth defects are exacerbated by deletion of HOG pathway genes SHO1, 
SSK1, STE50 and HOG1, and rescued by stimulating the HOG pathway and 
upregulating the PKC pathway. These findings suggested the possibility that MAPK 
pathways are defective in crd1Δ cells. Phosphorylation of Slt2p and Hog1p in response 
to stimulants was decreased in crd1Δ, consistent with defective activation of these 
MAPK pathways. Interestingly, upregulating PKC by transforming the cell with a vector 
expressing a constitutively activated Pkc1p rescued defective mitophagy in crd1Δ.  
These results suggest that the mechanism underlying defective mitophagy 
caused by loss of CL is a defective PKC pathway. 
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